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PLASMODIUM IMPAIRS ANTIBACTERIAL INNATE IMMUNITY TO SYSTEMIC 
INFECTIONS IN PART THROUGH HEMOZOIN-BOUND BIOACTIVE 
MOLECULES 
 
Christopher L. Harding 
June 13, 2020 
 
Despite efforts to decrease the global health burden of malaria, infections with 
Plasmodium species continue to cause over 200 million episodes of malaria each year which 
resulted in 405,000 deaths in 2018 [1]. One complication of malaria is increased 
susceptibility to invasive bacterial infections. Plasmodium infections impair host 
immunity to non-Typhoid Salmonella (NTS) through activities of heme oxygenase I 
(HO-I) )-induced release of immature granulocytes and myeloid cell-derived IL-10. Yet, 
it is not known if these mechanisms are specific to NTS. We show here, that Plasmodium 
yoelii 17XNL (Py) infected mice had impaired clearance of systemic Listeria 
monocytogenes (Lm) during both acute parasitemia and up to 2 months after resolution 
of Py infection that was independent of HO-I and IL-10. Py-infected mice were also 
susceptible to Streptococcus pneumoniae (Sp) bacteremia, a common malaria-bacteria 
coinfection, with higher blood and spleen bacterial burdens and decreased survival 
compared to naïve mice. Mechanistically, impaired immunity to Sp was independent of 
HO-I, but was dependent on Py-induced IL-10. Splenic phagocytes from Py infected 
mice exhibit an impaired ability to restrict growth of intracellular Lm, and neutrophils 
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from Py-infected mice produce less reactive oxygen species (ROS) in response to Lm or 
Sp. Analysis also identified a defect in a serum component in Py infected mice that 
contributes to reduced production of ROS in response to Sp. Finally, treating naïve mice 
with Plasmodium-derived hemozoin (Hz) containing naturally bound bioactive 
molecules, excluding DNA, impaired clearance of Lm. Collectively, we have 
demonstrated that Plasmodium infection impairs host immunity to diverse bacteria, 
including S. pneumoniae, through multiple effects on innate immunity, and that a 
parasite-specific factor (Hz+bound bioactive molecules) directly contributes to 
Plasmodium-induced suppression of antibacterial innate immunity. 
 
IMPORTANCE Our findings provide evidence that there are multiple factors involved 
in Plasmodium-induced suppression of antibacterial innate immunity. Given the 
increased mortality rate associated with malaria and invasive bacterial coinfections, these 
results may provide insight into new approaches to treat those individuals. Finally, this 
report provides the first description, to our knowledge, of a murine model system of 
Plasmodium and S. pneumoniae coinfection. In this model, Plasmodium infections impair 
host immunity to S. pneumoniae, which resulted in increased mortality. As S. 
pneumoniae is one of the most common bacteria identified in individuals with invasive 
bacterial infections during malaria, this model has the potential to provide further 
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Despite the advances in vaccine development and treatments of infectious 
diseases in recent years, protozoan parasites of the Plasmodium genus cause over 200 
million cases of malaria each year and in 2018 resulted in an estimated 405,000 deaths. 
The overwhelming majority of these fatal malaria cases occur in Africa (94% of total 
fatalities 2018) and children under 5 years old are most susceptible (67% of deaths 
worldwide in 2018) [1, 2].  Malaria is an ancient and widespread disease, caused by 
infection with protozoan parasites of the Plasmodium genus. As one of the most 
successful pathogens, Plasmodium has plagued humans for the entirety of our history, 
with the disease being mentioned in historical writings of ancient societies in China, 
India, Mesopotamia, Egypt and Greece [3]. Recent discoveries suggest that malaria 
significantly pre-dates human history, as dinosaurs were almost certainly infected with 
malaria-like parasites of the Paleohaemoproteus species. Supporting the theory that 
malaria may have played a role in extinction of the dinosaurs, 100 million year-old fossils 
of biting midge insect vectors have been found from the early Cretaceous period 
containing P. burmacis parasites [4]. Almost 200 species of Plasmodium have been 
described to date, infecting a wide variety of vertebrate hosts, including birds, reptiles, 
and other mammals [5]. There are currently around 30 different species of Plasmodium 
that are known to naturally infect non-human primates, and 5 are known to infect 
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humans, the most deadly of which is Plasmodium falciparum [6, 7].  Plasmodium 
employs female Anopheles mosquitoes as primary hosts and vectors that transmit the 
parasite to vertebrate secondary hosts while the mosquito acquires a bloodmeal [8].   
As its name suggests, malarial disease was historically attributed to “bad air” due 
to the early association between the disease and proximity to swamps and marshlands. In 
1897, Ronald Ross was able to demonstrate presence of pigmented parasite structures 
within mosquitos that had fed on blood of malaria patients, which then invaded the 
mosquitos’ salivary glands [3].  The parasite stage found in mosquito salivary glands is 
known as sporozoites, which are infectious to vertebrate hosts when transmitted by the 
bite of an infected mosquito (Figure 1). 
Figure 1. Lifecycle of Plasmodium Adapted from Michalakis and Renaud Nature 2009 “Malaria: 
Evolution in vector control” [9].  a. Female Anopheles mosquitoes requires a blood meal for development 
of their eggs. In the process, infected females inject the sporozoite form of the parasite into a human host. 
b. Sporozoites are carried in the bloodstream to liver cells, where they proliferate asexually, and then, as 
merozoites, invade red blood cells. c. Replication within red blood cells initiates the blood stage of malaria, 
which manifests as fever and chills. This precedes the production of male and female gametocytes that are 
transmitted back to a mosquito during a blood meal, where they fuse to form oocysts that divide to create 
sporozoites. These migrate to the mosquito salivary glands, where the cycle of infection starts again. 
Details of the life cycle differ for different species of Plasmodium.  Development within the mosquito takes 
10–14 days or longer. 
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Parasite lifecycle and malaria disease 
 
Within the human host, a small proportion of sporozoites exit the skin dermal 
layer by migrating to and penetrating a blood vessel within 1-3 hours [10].  From there, 
sporozoites travel through the bloodstream to the liver and actively transverse a capillary 
barrier, called sinusoids, until suitable hepatocytes (liver cells) are invaded. Here they 
undergo a process called schizogony, asexual reproduction where individual sporozoites 
divide and differentiate into merozoite daughter cells [11]. The liver-stage of 
Plasmodium’s lifecycle is clinically asymptomatic, making it an ideal target for vaccine 
development. Despite significant efforts, to date there are still no highly effective 
vaccines that target the liver stage [12]. Parasites within hepatocytes undergo schizogony 
within a membrane-bound vesicle, known as merosomes, which develop for 10-12 days 
in the liver during P. falciparum infection.   Merosomes are released from hepatocytes 
and enter the blood where they rupture and give rise to up 40,000 merozoites per 
merosome.  In the bloodstream merozoites go on to infect erythrocytes (red blood cells), 
initiating the blood-stage of the Plasmodium lifecycle [13].   
Blood-stage malaria consists of a chronic cycle of asexual schizogony where 
merozoites infect a new erythrocyte, undergo multiple rounds of intracellular asexual 
reproduction for a period of 48 hours.  Infected erythrocytes exhibit synchronized 
development  and their simultaneous release from host cells and elicit a robust 
inflammatory immune response [14].  This 48-hour lifecycle, combined with an apparent 
ability to sense the hosts’ circadian rhythm, is thought to either increase chances for 
transmission to a new mosquito vector [15, 16], or for optimal avoidance of host immune 
responses when extracellular parasites are most vulnerable [17, 18].  This timed parasite 
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release into the bloodstream is also responsible for the characteristic cycling fevers 
generally associated with malaria.   
Symptoms of uncomplicated malaria include bouts of fevers lasting 6 to 10 hours, 
headaches, nausea and vomiting, as well as body aches and general malaise.  
Manifestations of severe malaria are more likely to occur in children under 5 years old, 
pregnant women, immune-compromised individuals such as those with HIV/AIDS, and 
non-immune persons or travelers who have not had previous exposure to Plasmodium 
[19].  The complications of severe malaria are often fatal and can materialize as cerebral 
malaria, severe anemia, acute respiratory distress syndrome, and others related to 
hyperparasitemia, which refers to a high proportion of infected red blood cells (greater 
than 5% in humans) [20].  Enlargement and swelling of the liver and spleen are also 
common and splenic rupture is possible, though quite rare.  Since symptoms of malaria 
do not differ significantly from many other infectious diseases, diagnosis of malaria 
generally requires the demonstration of parasites in a blood smear [21].  Plasmodium 
infections that are left untreated can last from several weeks to months, and prolonged 
low-level (low parasitemia), asymptomatic infections can last several years with delays in 
clinical symptoms as high as 2, 4, or even 8 years after exposure [22-24]. 
 
Malaria geography and burdens of disease 
 
The geographical range of malarial disease is currently restricted to tropic and 
subtropical regions (Figure 2).  Global climate change threatens to increase vector 
stability in regions that have had little to no transmission of malaria in the past century, as 




Figure 2. Case incidence rate of malaria, 2018 (cases per 1,000 population at risk). Adapted from 
World Malaria Report 2019 
 
Among the many reasons that the massive efforts to “eradicate” malaria have 
fallen short so far, the prevalence and persistence of the Anopheles mosquito vector, 
maintenance of the parasite within its human reservoir (including asymptomatic 
infections), and the emergence of drug and insecticide resistance represent major 
challenges to Plasmodium eradication [25-29].  Malaria disproportionally impacts parts 
of the world with the highest levels of poverty, which is clear when considering countries 
that eradicated malaria in the second half of the 20th century had significantly higher 
economic growth after eliminating the disease than their malaria plagued neighbors [30].  
The debilitating effects of moderate and even mild malaria cases also have a major 
negative impact on cognitive function, learning, and the number economic opportunities 
individuals in malaria endemic regions are able to capitalize from [31, 32].  When 
considering the economic burdens and time spent caring for infected individuals, the 





Figure 3 Climate change models predict increase in vector stability in Europe.  Adapted from Hertig 
2019 (Parasit Vectors) [33]. 
 
Immune response during malaria 
The clinical disease ‘malaria’ is mainly driven by the host’s inflammatory 
immune response, where a carefully regulated effort is needed to be able to successfully 
clear the parasite while also avoiding collateral damage of host tissues.  Although the 
host immune system recognizes infected hepatocytes, failure to eliminate every infected 
hepatocyte results in progression to the blood-stage of infection [34].  At the onset of 
parasite replication in the bloodstream, cells of the innate immune system recognize 
molecular signatures of the parasite that activate them to either engulf and kill cell free 
parasites and infected red blood cells (a process called phagocytosis), produce toxic 
substances that kill Plasmodium, and attract other immune cells that function to eliminate 
Plasmodium [35].  Innate cells such as dendritic cells and macrophages can act as antigen 
presenting cells that communicate with the adaptive immune system by presenting pieces 
of the parasite directly or produce chemical signals that help initiate an adaptive immune 
response that will be developed specifically to the invading microorganism.  Neutrophils, 
also called polymorphonuclear neutrophils (PMN), respond to Plasmodium infection 
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through the release of reactive oxygen species (ROS) and granules, which are internal 
compartments that store other toxic molecules capable of killing Plasmodium parasites 
and other microorganisms [36].  While PMNs are quickly mobilized, they generally live 
for 24 hours or less.  In contrast, macrophages are long-lived cells capable of 
phagocytosing and killing parasites and infected red blood cells [37].  Macrophages in the 
spleen, an organ that functions to filter the blood, normally uptake and remove damaged 
red blood cells. During Plasmodium infection macrophages phagocytose free parasites 
and infected red blood cells, thereby preventing uncontrolled replication that would lead 
to hyperparasitemia [38, 39].  
Another aspect of the immune system that is involved in infections is the 
complement system.  Components of this system can bind pathogens directly causing 
their destruction and send recruitment signals to attract immune cells.  Infected cells or 
pathogens bound with complement components are “tagged” for destruction by innate 
immune cells.  Complement also interacts and cooperate with antibodies as a separate 
mechanism for improved pathogen neutralization [40]. While the innate immune system 
protects the host from an overwhelming Plasmodium infection, efficient clearance of 
Plasmodium is mediated by the ensuing adaptive immune system [41]. 
 
Malaria and secondary coinfections  
 
In Plasmodium endemic areas, malaria was identified as a major risk factor for 
developing bacteremia that correlated with a worse clinical outcome and higher 
morbidity [42-49].  Evidence of bacterial coinfections with malaria have been found in 
analysis of 4 heads of mummies from ancient Lower Egypt in ca. 800, where DNA 
analysis found the co-occurrence of P. falciparum with Tuberculosis [50].  More 
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recently, in four separate clinical studies conducted in sub-Saharan Africa, between 4 and 
23% of children with severe malaria had concomitant sepsis [42, 49, 51, 52].  A 
population-based case study found that in a malaria-endemic region of Kenya, authors 
estimated that malarial disease predisposed children to bacteremia and accounted for 
more than half of all bacteremia cases [42].  Finally, a systematic review of clinical 
studies revealed that African children (from 25 different studies in 11 different countries 
that met criteria) with recent or acute malaria are at risk of bacterial infection and that 
such coinfections resulted in increased risk of mortality [53].  Gastrointestinal and 
pulmonary bacterial pathogens such as non-typhoid Salmonella (NTS) and Streptococcus 
pneumoniae (Sp), respectively, are the most common organisms isolated from blood of 
Plasmodium-bacteria co-infected individuals [42, 45, 49, 51, 52, 54, 55]. 
A 2010 meta-review of invasive bacterial infections in Africa reported that across 
all studies having appropriate diagnostic methods, approximately 6.5% of patients with 
Plasmodium positive blood smears also had a concomitant  bloodstream fungal or 
bacterial infection [45].  Several clinical reports have identified NTS as the most 
prevalent bacterial pathogen isolated in blood of malaria patients and some also mention 
that this trend is especially prominent during rainy seasons, when transmission of 
Plasmodium falciparum is more frequent [56].  Clinicians also observed a difference in 
the pathogenic nature of NTS infections occurring simultaneously with malaria. 
Normally, NTS infections are limited to the gastrointestinal tract and result in overt 
diarrheal disease with little to no systemic invasion to other tissues due to control of 
infection via the innate immune response [57]. However, during coinfection with 
Plasmodium, NTS is able to colonize the intestines and disseminate systemically, 
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resulting in bacteremia [58]. The recognition of strong correlation between malaria and 
invasive bacterial infections from analysis of clinical observations has provided 
researchers with sufficient rationale to investigate the mechanisms by which Plasmodium 
infection increases host susceptibility to NTS.  Currently, studies conducted with both 
mouse models of malaria and samples from malaria patients suggest that enhanced 
susceptibility to NTS is due to hemolysis and anemia related to the parasite infection, but 
have not identified a parasite factor to be involved [59-64].  
 
Other malaria coinfections: 
  Other than NTS and Sp coinfections with malaria, the incidence of malaria with 
several other concomitant bacterial, viral, fungal, and protozoan pathogens have been 
reported.  A long history of malaria occurring simultaneously with Tuberculosis is 
indicated by researchers who have found evidence of this coinfection during molecular 
analysis of Egyptian mummy remains [50].  Although incidence of malaria is 
geographically associated with rural areas and tuberculosis is more prevalent in areas 
with higher population density, there are reports of malaria occurring in 3% of 
tuberculosis patients in an epidemiological study in Tanzania and another in Angola 
demonstrated malaria coinfections in over 37% of tuberculosis patients [65, 66]. Finally, 
a study in Guinea-Bissau found that malaria was associated in an increased mortality in 
tuberculosis infected individuals and showed an improved outcome for tuberculosis 
patients when transmission of malaria was prevented [48].  Given the general endemicity 
of malaria and tuberculosis, studies have been conducted to determine the interaction 
between the Mycobacterium bovis (BCG) vaccine strain, or the fully virulent 
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Mycobacterium tuberculosis, which causes human tuberculosis disease, and immunity to 
malaria.  While some studies demonstrated that BCG conferred protection against a 
normally lethal Plasmodium strain in a murine model, others have shown either enhanced 
severity of malaria or exacerbation of acute BCG infection or M. tuberculosis (see Table 
1) [67]. 
Table 1. Malaria-Tuberculosis coinfection studies in murine models. These studies suggest tuberculosis 
infection can modulate immune response to subsequent Plasmodium infection and influence the clinical 
outcome. Adapted from dissertation of R. Frita, 2014 University of Lisbon, “Malaria and Tuberculosis 
coinfection: a role for Hemozoin immunosuppression” 
 
 
Other respiratory bacterial infections such as Haemophilus influenzae, 
Staphylococcus aureus, and Pseudomonas aeruginosa or gastroenteric pathogens like E. 
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coli and cholera have been identified in patients with malaria, but these coinfections are 
not as commonly detected as NTS, Sp or tuberculosis – mentioned above.  
 
Malaria HIV coinfections 
With the multitude of information known about immune suppression and 
increased susceptibility to secondary infections in HIV positive individuals, and the large 
overlap in geographical endemicity of HIV and malaria, it is crucial to understand the 
interactions between the two pathogens and how they may influence an individual’s 
immune response to an invasive bacterial infection.  It has been demonstrated that 
malaria can enhance viral replication in HIV coinfections and reactivate latent infection  
[68-70].  Malaria-driven cytokine responses and inflammation contribute to this by 
inducing the activation of CD4+ T cells and rendering them more susceptible to viral 
invasion and replication [69].  This coinfection was associated with higher viral loads in a 
clinical study in rural Malawi and East sub-Saharan Africa [69, 71].  It has also been 
shown in vitro that treatment with the parasite by-product, hemozoin, increases the HIV 
RNA load in human peripheral blood mononuclear cells (PBMCs), as well as lead to 
functional defects in monocyte-derived DCs and monocytes which impede maturation 
and promote transfer of HIV-1 to CD4+ T-cells [72-74]. 
In respect to the work exhibited here, due to the widespread incidence of HIV in 
sub-Saharan Africa, it will be important for future studies to examine how HIV and AIDS 
complicates and likely further impairs immunity to bacterial coinfections during malaria.  
It would also be diligent of clinicians to make an intentional effort to test for and report 
HIV status, tuberculosis infection, and any acute or recent malaria episodes when 
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accumulating data or presenting clinical reports.  This information is important to provide 
researchers with a more complete picture of the interplay between these three highly 
endemic pathogens so that we may design more appropriate studies to explore their 
complex interactions and mechanisms of manipulating host immunity to invasive 
bacterial diseases. 
The risk of developing bacterial sepsis is significantly higher in individuals with 
severe malaria and this combination is associated with increased mortality [49, 75, 76].  
This major global health problem is compounded by the lack of  availability of accurate 
testing in malaria endemic areas.  Additionally, while malaria is commonly over 
diagnosed, only one third of cases of invasive bacterial disease are accurately diagnosed, 
leading to the misuse of antibiotic treatments [75].  Aside from the difficulties of 
obtaining the information in the clinic for optimal treatment of patients with these 
coinfections, there is a fundamental lack of understanding of the mechanisms that 
increase host susceptibility to invasive bacterial disease during malaria. The aim of this 
work is to expand our knowledge of the factors by which the Plasmodium parasites 
impair host immunity to bacterial coinfections, and expand beyond what has already been 
learned about coinfections with non-Typhoid Salmonella.  In this work I also seek to 
provide evidence that the parasite factor, hemozoin, contributes to impaired bacterial 
immunity, introduce a novel method of hemozoin isolation and the first murine model of 
Plasmodium Pneumococcal coinfection.  Scientific efforts in all fields related to malaria 
are of critical importance considering the inextricable connection between this disease 
and poverty human suffering. A temporally suitable comparison can be made between the 
current pandemic with COVID-19 which has had major global consequences. At the time 
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this is written, there are nearly 7.5 million confirmed cases and 420,000 deaths from 
COVID-19 worldwide, while in 2018 malaria infected 200 million people and killed over 
400,000 people [2, 77].  Although the mortality rate of COV-SARS2 is considerably 
higher, this comparison offers a useful way to reflect on the overall public health burden 
of malaria.  For these reasons, it is essential that we improve the public health of the 
impoverished communities most heavily affected by conducting research that aims to 
understand the interactions between Plasmodium and host immunity, as well as the other 






















Female C57BL/6N mice 6-12 weeks old were obtained from Charles River Laboratories 
(Wilmington, MA) and housed at the University of Louisville under appropriate biosafety 
level conditions. All mice were housed in a specific pathogen-free facility and 
acclimatized for a minimum of 7 days before starting experiments. Male mice are 
generally more prone to higher parasitemia, more severe Plasmodium infections, and 
often become moribund [78-80].  Since we are not interested in gender differences, and to 
have more comparable groups, only female mice will be used for all experiments 
Animals were fed the NIH-31 diet (Modified Open Formula Mouse/Rat Irradiated Diet; 
Harlan 7913; Envigo, Indianapolis, IN) and provided autoclaved, non-acidified reverse-
osmosis water ad libitum. The mice were kept on a 12-hour light/dark cycle from 6 AM 
to 6PM and 6PM to 6AM, respectively. All animal handling and experimentation were 
reviewed and approved by the University of Louisville Institutional Animal Care and Use 
Committee based on the recommendations of the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health. 
 
Infections 
Plasmodium yoelii: Mice were infected i.v. with 5x106 parasitized red blood cells 
(pRBC) Plasmodium yoelii 17XNL (Py). Parasitemia (% of infected red blood cells) was 
determined by analyzing samples of peripheral blood obtained from day 5 post Py 
infection and alternating days afterward until mice cleared the infection. Blood samples 
were fixed in 0.02% glutaraldehyde and stained with antibodies specific to CD45-APC 
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(clone 104) and Ly-76 (clone Ter119) from Biolegend (San Diego, CA) and dyes 
dihydroethidium, and Hoechst 33342 (Sigma-Aldrich, St. Louis, MO). Parasitemia was 
analyzed with flow cytometry using a BD Fortessa, where pRBCs were identified as the 
population of CD45- , Ter119+, dihydroethidium+, Hoechst+ cells.  All flow cytometry 
data was analyzed with FlowJo software. 
Plasmodium berghei: Mice were infected via intraperitoneal injection with 1x104 
pRBCs of strain NK65 or mutants obtained from peripheral blood preparations of 
infected donor mice. In the NK65 infections were initiated with wild type, Δdpap, Δpm4 
strains kindly provided by Dr. Phileppe Van den Steen at University of Leuven, Belgium 
[81]. Parasitemia was tracked on days 6, 7, and 9 post infection and Lm infection was 
initiated as with Py coinfections, on day 7 post Pb.  Parasite burdens were determined as 
described for Py.  
 Listeria monocytogenes: Strain 1043S actA-deficient Listeria monocytogenes, or 
1043S wild type, were grown from freezer stock aliquot in tryptic soy broth and then 
washed with PBS and resuspended in sterile saline. Mice were infected i.v. with 
5x106(ActA-), or 1x104(wildtype 1043S)  CFU on indicated days post Py infection or as 
an initial infection in age-matched mice. 
 Streptococcus pneumoniae: S. pneumoniae (Sp) ATCC strain 6303, a type 3 
capsule isolate cultures were started from freezer stocks and grown in brain heart infusion 
broth containing 50mM HEPES buffer and incubated statically at 37˚C with 5% CO2. 
Cultures were washed in PBS and resuspended in sterile saline. Mice were infected with 
1x106 CFU of Sp intranasally to naïve mice or Py infected mice on day 7 post Py 
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infection in a volume of 30μl.  Inoculum dose was confirmed by plating serial dilutions 
on blood agar and counting colonies after 12 to 18 hours of growth at 37˚C with 5% CO2. 
Salmonella enterica serovar Typhimurium (NTS): Frozen aliquots of Salmonella 
enterica serovar Typhimurium strain 12023 were thawed and resuspended in LB broth 
and grown shaking at 37˚C.  Cultures were then washed in sterile 1X PBS and 
resuspended in sterile saline. Mice were infected on day 10 post Py infection via 
intraperitoneal injection of 1x103 cfu in 200μl.  Inoculum dose was verified by plating 
serial dilutions on LB agar containing 50μg/mL carbenicillin. 
 
Bacterial burden quantification analysis 
Spleens and livers from Lm infected mice were collected in 0.2% IGEPAL 
(Sigma Aldrich, St. Louis, MO) at the indicated time points. Organs were homogenized 
and plated in serial dilutions on tryptic soy agar plates with 50 μg/mL streptomycin. 
Lungs and spleens from Sp infected mice were collected in sterile 1X PBS. Organs were 
homogenized and plated in serial dilutions on tryptic soy agar plates supplemented with 
10% sheep blood (company, city state). Peripheral blood was collected via retro-orbital 
bleed and plated directly on tryptic soy agar plates with 10% sheep blood agar.  For 
analysis of bacterial burdens in NTS infections, peripheral blood and organ homogenates 







In vivo Inhibition of IL-10 and HO-1 
Py-infected and naïve mice were injected i.p. with 300, 200, and 100μg of rat 
anti-IL-10 IgG1 kapa monoclonal antibody (clone JES5-2A5) or rat anti-horseradish 
peroxidase IgG1 isotype control (InVivoMAb, West Lebanon, NH) in 0.2 mL sterile 
saline on days Py+6, 7, and 8 for Lm coinfection (day Lm -1, 0, and +1), days Py+7, 8, 
and 9 for Sp coinfection (day Sp -1, 0, and +1), and days Py+9, 10, and 11 (days NTS -1, 
0, +1) for NTS coinfections.  Similarly, Py-infected and naïve mice were treated i.p. with 
40μmol/kg Tin Protoporphyrin IX (chloride) (Sn PP) (Cayman Chemical, Ann Arbor, 
MI) in 0.2mL 1X PBS on days Py+5, 6, 7, and 8 for Lm coinfection (day Lm -2, -1, 0, 
and +1), days Py+6, 7, 8, and 9 for Sp coinfection (day Sp -2, -1, 0, and +1), and days 
Py+8, +9, 10, and 11 (days NTS -2, -1, 0, +1) for NTS coinfections. 
 
In vivo IFNγ inhibition and recombinant IFNγ treatments 
Neutralization of IFNγ activity was achieved by treating mice with i.p. injections 
of 0.5mg anti-IFNγ monoclonal antibody (clone XMG1.2) (InVivoMAb) suspended in 
0.2ml sterile saline 8 hours before Lm infection and 1- and 2- days post Lm infection.  
Treatment was only given to Lm only groups, while a separate Lm only and coinfected 
groups were given i.p. injections of 0.2ml sterile saline.  In contrast, 0.5 mg of  
recombinant IFNγ (Abcam, Cambridge, MA) was given to coinfected mice in 3 separate 
i.p. injections in 0.2ml sterile saline 8 hours before Lm infection and also 1- and 2- days 





Splenic myeloid cell analysis 
Spleens were removed on the indicated days post Py infection or from age-
matched naïve mice and placed in HyClone  RPMI 1640 (Thermo Fisher Scientific, 
Waltham, MA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, 
Lawrenceville, GA), 1.19 mg/ml HEPES (Corning, New York, NY), 0.2 mg/ml L-
glutamine (Research Products International, Mt. Prospect, IL), 0.05M 2-mercaptoethanol 
(Thermo Fisher Scientific), 0.05 mg/mL penicillin/streptomycin (Invitrogen, Grand 
Island, NY), and 0.05 mg/mL gentamicin (Corning). Single cell suspensions were treated 
with ammonium chloride potassium solution (0.15 mM NH4Cl, 1.0 mM KHCO3, 0.1 mM 
Na2 EDTA, 1 N HCl) to lyse red blood cells and then washed in RPMI then resuspended 
in FACS buffer (1XPBS, 1%FBS, 0.02% sodium azide) containing Fc block (anti-
CD16/32; clone 2.4G2). Splenocytes were then stained with cell surface marker-specific 
antibodies. Anti-CD3ϵ FITC (clone 145-2C11), anti-CD19 FITC (clone 6D5), anti-
CD11b PE/Cy7 (clone M1/70), anti-CD11c BV650 (clone N418), anti-Ly-6G BV421 
(clone 1A8), anti-Ly-6C PerCP/Cy5.5 (clone AL-21), anti-F4/80 PE Dazzle 594 (clone 
BM8) were from Biolegend (San Diego, CA). Anti-CD209b APC (clone eBio 22D1), 
anti-CD169 (clone SER-4) were from eBiosciences (San Diego, CA). Anti-SIGLEC-F 
APC R700 (clone E50-2240) was from BD Pharmingen (San Diego, CA). Cells were 
incubated with antibodies at 4˚C for 15 minutes. Cells were then fixed in 4% 
paraformaldehyde fixation buffer (Biolegend) and then washed three times in FACS 





Spleen phagocytic cell isolation and intracellular bacterial survival assay 
Single cell suspensions from 3 naïve or Py infected mice were generated as 
described above and pooled together. Splenic phagocytes were enriched by negative 
depletion of CD3+ and CD19+ cells using anti-CD3ϵ and anti-CD19 microbeads (Miltenyi 
Biotec, Bergisch Gladbach, Germany), according to manufacturer recommendations. 
CD3- and CD19- flow through cells were stained with anti-CD11b PE/Cy7 (clone M1/70) 
and CD11c APC (clone N418) from Biolegend (San Diego, CA). CD11bhi/CD11c- cells 
were sort purified with a BD FACSAria III. Sorted cells were plated and incubated at 
37˚C with 5% CO2 for 1 hour. For some experiments, cells from naïve mice were 
incubated for 30 minutes with 30μg Py hemozoin (PyHz). Sorted cells were infected with 
Lm that had been opsonized by incubating in RPMI with 10% homologous mouse serum 
(naïve cells + Lm opsonized with naïve serum; Py cells + Lm opsonized with Py serum) 
rotating for 30 minutes at 37˚C. Bacteria was washed once in RPMI and cells were 
infected with a multiplicity of infection (MOI)=100. One hour after the infection, media 
was removed from cells and replaced with RPMI containing 5 µg/mL gentamicin to kill 
extracellular Lm.  Intracellular Lm burden was determined after 1 hour and 4 hours of 
incubation in RPMI with gentamicin by removing the media containing gentamicin and 
resuspending the cells in sterile deionized H2O (dH2O) to lyse cells and release surviving 
Lm. Fold change in intracellular Lm was determined by dividing cfu at 4 hours post 







Cells were from either peripheral blood, obtained through tail snip, or spleen or 
liver single cells isolated and passed through a 100-micron pore size nylon mesh. In some 
experiments, CD11bhi/CD11c- cells were sort purified from T cell and B cell depleted 
spleen samples.  Blood samples were smeared on a glass slide and allowed to dry, spleen 
and liver cells were placed onto a glass slide in a drop of RPMI containing 15% mouse 
serum and incubated at 37˚C with 5% CO2 for 30 minutes to allow cells to adhere. For all 
samples, cells were fixed in methanol for 20 minutes and stained with Giemsa dye (Azer 
Scientific, Morgantown, PA) for 20 minutes and rinsed with ddH2O. In some cases, cells 
were incubated with Hz as described above and Hz is visible as brown pigment. Images 
were obtained with a Nikon eclipse Ci light microscope at 100X magnification or a Zeiss 
Axio Imager .A1 microscope with an AxioCam MRm digital camera (Zeiss) at 63 or 96X 
in oil emersion.  Scale bars were estimated based on average diameter of murine 
erythrocytes (Nikon) or with Axiovision SE64 imaging software (Carl Zeiss Microscopy, 
LLC, White Plains, NY). 
 
Isolation of P. yoelii-derived hemozoin (PyHz) 
Livers and spleens were obtained from mice previously infected with Py after 
clearance of the parasite infection, between 30- and 65-days post-infection. Organs were 
collected and homogenized with a tissue homogenizer in de-ionized H2O (dH2O) and 
kept on ice for 1 hour. Homogenates were centrifuged at 3100 x g for 10 minutes. Pellets 
were washed twice in dH2O and passed through 100-micron nylon mesh (ELKO Filtering 
Co.). Flow-through was collected, washed and resuspended in sterile PBS before being 
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added to the top of a discontinuous Percoll density gradient containing 40% (1.07g/mL) 
and 80%(1.12g/mL) fractions. Gradients were centrifuged at 5,000 x g for 20 minutes 
with slow acceleration/deceleration at 4˚C. Hemozoin from Py infected mouse organs 
(PyHz) was collected from the interphase between the 40% and 80% fractions, as well as 
from the dark pellet beneath the 80% fraction. Samples were washed twice in dH2O and 
finally resuspended in sterile PBS. Purification of ‘clean’ PyHz was performed for some 
experiments with a method adapted from Coban et al. [82], where organ homogenate was 
lysed in 0.2% IGPAL and washed 3-4 times in 2% sodium dodecyl sulfate (SDS) and 
then incubated overnight in 10mM Tris-HCl (pH 8.0), 0.5% SDS, 1mM CaCl2, and 
2mg/mL proteinase K at 37˚C.  Next, samples were washed again in 2% SDS and then 
incubated at 37˚C for 3 hours in 6M urea, washed in 1X PBS and resuspended in saline 
for experimental use.  For quantification of Hz in mouse tissues, organs were 
homogenized and incubated in 1% Proteinase K (VWR, Solon, OH) overnight at 37˚C. 
Hz was quantified using a protocol adapted from Deroost, et al., 2012 [83]. Briefly, Hz 
was centrifuged at 3100 x g and pellets were washed three times in 100mM NaHCO3, pH 
9.0 with 2% SDS.  Hz, and a dilution series of synthetic hemozoin (InVivoGen, San 
Diego, CA) of known concentration, were resuspended in 100mM NaOH, 2% SDS, 3mM 
EDTA and then sonicated for 5 minutes before incubating for 30 minutes at room temp to 
dissolve hemozoin into soluble heme. Quantification was determined by reading 
absorbance at OD400 and comparing values of samples prepared from Py-infected mouse 
organs to the synthetic Hz standards. For some experiments, PyHz was incubated at 37˚C 
in 100 U/mL DNase with 1mM CaCl2 and 2mM MgCl2 for 2 hours. These samples were 
then washed twice in 2mM mannitol-containing phosphate buffer and resuspended in 
22 
 
sterile saline. Absence of DNA in PyHz sample was verified by staining with GelRed 
Nucleic Acid stain and running samples on 1% agarose gel. 
 
Plasmodium falciparum culture and preparation of hemozoin  
Natural P. falciparum hemozoin (PfHZ) was prepared from in vitro human 
erythrocytes cultures infected with P. falciparum (Palo Alto strain, mycoplasma-free) 
treated with DNase (Sigma, St. Louis, MO). Contamination with endotoxin (LPS) was 
excluded by E-Toxate assay (Sigma, St. Louis, MO), as previously described [84]. 
Briefly, synchronized parasite cultures were supplemented with DNase (5 U/ml) 12-15 
hours previous to schizogony. PfHZ which was naturally expelled during schizogony, 
was harvested at the 25/40% interface of a discontinuous percoll gradient, incubated with 
40U/ml DNase, 2 mM MgCl2 and 1mM CaCl2 in PBS at 37°C for 1h and subsequently 
washed several times in a 10 mM phosphate buffer (pH 8.0) containing 2 mM mannitol. 
HZ was quantified by its heme content using a luminol-enhanced luminescence assay as 
previously described [85]. 
 
In vivo Hz treatments  
Mice were treated with 1-1.5mg of the indicated preparations of Hz intravenously 
by injection through the tail vein, or retro-orbital vein.  Prior to injection, Hz was washed 
twice from storage solution, 1X PBS with 2mM Mannitol and 20mM HEPES with 1X 
PBS and resuspended in sterile saline.  The entire volume of the final Hz preparation was 
then passed 3 to 5 times through a series of syringe needles with 21, 25, 27.5 , and 30 ½ 
gauges.  Mice were then slowly and carefully injected with 200 to 300μl of Hz to avoid 
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cardio-pulmonary distress. In some cases, mice received 2 injections to achieve a total of 
1-1.5mg on consecutive days.  Lm or Sp infections were initiated 7 days after Hz 
infections  
 
Reactive oxygen species assay 
Spleens and blood (for opsonizing bacteria) were collected from naïve control and 
Py-infected mice (days 10-16 post infection). Spleens were processed to generate single 
cell suspensions. Cells were plated at 2x106 cells/well resuspended in RPMI with 10% 
fetal calf serum incubated at 37˚C for 30 minutes with 5% CO2. Cells were then 
incubated with the following antibodies; anti-CD3ϵ APC (clone 145-2C11), anti-CD19 
APC (clone 6D5), anti-CD11b PE/Cy7 (clone M1/70), anti-Ly-6G BV421 (clone 1A8), 
and 2’,7’-dichloro-hydrofluorescein diacetate (DCF; Abcam Cambridge, MA) for 20 
minutes. Cells were then left untreated or treated for 20 minutes at 37˚C with 5% CO2 
with 20 μM phorbol 12-myristat 13-acetate (PMA), unopsonized Lm or Sp, naïve serum 
opsonized Lm or Sp, or Py serum opsonized Lm or Sp at an MOI of 10 Sp was heat 
treated (Ht Sp) at 65˚C for 1 hour. Lm and Ht Sp were opsonized in 10% serum, from 
naïve or Py-infected mice, in RPMI while incubating at 37˚C and rotating. After 
treatment, cells were centrifuged at 300 x g for 5 minutes then incubated at 37˚C for 20 
minutes followed immediately by analysis on a BD LSRFortessa. 
 
Statistical analysis 















An association between malaria and increased susceptibility to invasive bacterial 
disease has been recognized by several clinical reports.  With the exception of emerging 
insight into mechanisms by which malaria increases susceptibility to NTS, there is still 
little known about the underlying mechanisms by which Plasmodium infection 
suppresses host antibacterial immunity.  In regard to NTS, Plasmodium-induced 
hemolysis results in the activation of heme oxygense-1 (HO-1), which mobilizes 
functionally immature granulocytes from the bone marrow.  These immature 
granulocytes exhibit impaired production of reactive oxygen species in response to PMA 
stimulation, and decreased killing of NTS [62].  Similar impairments to NTS immunity 
were observed when mice were treated with phenylhydrazine to induce hemolysis or 
hemin to mimic hemolysis, leading to the conclusion that impaired bacterial immunity 
during Plasmodium infection is attributed to hemolysis with no parasite-specific factor 
contributing to the immunosuppression [61].  Additionally, Plasmodium-induced IL-10 
from myeloid cells suppresses the ability of myeloid cells to control NTS, resulting in 
increased systemic colonization in co-infected mice [59].  Moreover, IL-10 signaling 
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through the IL-10 receptor can directly induce HO-1 to suppress anti-bacterial immunity, 
creating an environment that favors intracellular growth and dissemination of NTS [86].   
 Streptococcus pneumoniae (Sp), also known as “Pneumococcus”, is a commensal 
bacterium in the human nasopharynx, but is capable of causing disease when symbiosis 
between the bacterium and host is disrupted.  A systemic review of pneumococcal 
carriage in sub-Saharan Africa found children under 5 years old had approximately 60% 
carriage, while children 5-15 years old had about 40% carriage [87].  When symbiosis 
between the host and Sp is disrupted, Sp can cause a variety of infections including; 
pneumonia, sinusitis, otitis media, bacteremia/sepsis, and meningitis [88].  Importantly, 
pneumococcus has been identified as one of the most common pathogens isolated from 
blood samples of children in Africa with invasive bacterial infections [45].   
While clinical studies do not unanimously agree that Sp is frequently concomitant 
with malaria, several features of these studies may be limiting Sp detection.  For 
example, one study that presented low abundance of Sp detected in blood of children 
with malaria excluded patients that showed signs of respiratory tract illness, a symptom 
that is commonly associated with malaria and MA-ARDS and would be likely to occur in 
a patient with invasive pneumococcal disease [46]. The same study reported a high 
amount of known contaminant organisms, such as Staphylococcus aureus, which 
accounted for 43% of all bacteria isolated from blood cultures, compared to 3% Sp.  
Other factors that could have decreased Sp detection are its fastidious nature in culture, 
tendency to autolyze during static growth conditions, and many diagnostic labs may not 
have the resources on hand to examine Gram stains, colony morphology, and hemolysis 
phenotype [89].  Contrary to these potentially problematic reports, several broad scale 
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clinical reviews have shown that Sp is among the bacterial infections most commonly 
found in association with malaria in children (Reddy et al., Churchet al.) and adults 
(Aumaet al., Morton et al., Nadjm et al., and Reddy et al.) [43-45, 53, 90].  Moreover, an 
analysis of Mozambican children in a rural hospital identified Sp as the leading pathogen 
associated with malarial anemia and severe malaria [91].  In contrast to NTS, to our 
knowledge there are no mechanistic studies that have assessed the interaction between 
malaria and Sp coinfection, and no animal models of malaria and Sp infection have been 
described. To this end, I have developed a malaria and Sp coinfection mouse model. 
The outcome of malaria depends in large part on the timing and magnitude of 
cytokine production, and the balance of inflammatory and immune suppressive responses 
induced by Plasmodium infection.  There is a well-known correlation between the 
severity of malarial disease and high levels of systemic IFNγ, TNFα and other pro-
inflammatory cytokines [92-94].  Ideally, these cytokine signals work synergistically to 
orchestrate the production of anti-parasitic factors like NO and other radicals [95].  To 
balance these pro-inflammatory responses, the host induces anti-inflammatory cytokines, 
in particular TGF-β and IL-10.  Yet, elevated levels of these anti-inflammatory cytokines 
can also lead to increased mortality and hyperparasitemia [96-98].   
While cytokines play a major role in both innate and adaptive immune responses 
during malaria, IL-10 activity during malaria in particular has garnished attention as a 
potential contributor to Plasmodium-induced suppression of immunity to non-typhoid 
Salmonella [59, 99].  Observations have been made in laboratory animal studies and 
human clinical studies that show an IL-10-dependent inhibition of neutrophil function 
and recruitment to infected tissues during acute and recently cleared Plasmodium 
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infections, making a clear case for IL-10 in suppressing immunity to bacterial 
coinfections.  Experiments conducted by the laboratory of Renee Tsolis found that P. 
yoelii-infected IL-10 deficient mice as well as P. yoelii-infected mice treated with anti-
IL-10 antibody to block activity had decreased systemic levels of non-Typhoid 
Salmonella following the secondary infection [59].  Alternatively, the Tsolis group found 
mice treated with recombinant IL-10 elevated bacterial burdens similar to both P. yoelii-
infected mice and mice with anti-RBC antibody treatment-induced anemia [59].  The 
connection between IL-10, anemia, and Plasmodium infection also involves heme 
oxygenase-1, an enzyme also linked to increased susceptibility to non-Typhoid 
Salmonella during malaria – whereby both IL-10 and free heme during anemia can 
independently induce HO-1 [62]. This interaction that renders a host with limited anti-
Salmonella immunity is fundamentally linked to parasite-driven hemolysis during blood-
stage malaria, where the continuous rupture of schizonts from infected erythrocytes leads 
to anemia. The physiological effects of anemia eventually normalize as homeostasic 
concentration of RBCs/mL blood occurs within 10 days of parasite clearance from 
circulation [62].  Together, these mechanisms are thought to impair neutrophil functions, 
recruitment and activation of innate immune cells, thereby providing an environment 
which favors the growth of Salmonella and systemic spread of invasive infection.   
Since the overall goals of this work relate to the impact of Plasmodium infection 
on immunity to bacterial coinfection, it is critical to consider whether factors that are 
known to be involved in the heightened susceptibility to Salmonella during malaria are 
also important in other bacterial coinfections.  The limitation of malaria-bacterial 
coinfection mechanistic studies to Plasmodium and NTS creates a knowledge gap as it is 
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unknown whether the mechanisms of Plasmodium-driven immune suppression are 
specific to NTS or if they will apply broadly to all invasive bacterial infections.  
Furthermore, no parasite-specific factor has been identified to contribute towards 
Plasmodium-induced impaired immunity to bacterial coinfections.  These represent 
important knowledge gaps that impede treatment of bacteria coinfections during malaria.  
The focus of this chapter is dedicated to testing the nature of Plasmodium-
bacterial coinfections other than NTS, and also determine whether the same hemolysis-
dependent mechanisms found to impair immunity to NTS are involved.  While some 
progress has been made in exploring the factors involved in Plasmodium-induced 
susceptibility to NTS infection, there is a critical need for additional animal model 
systems to investigate other coinfections with malaria.  One of the overall aims of this 
work is to provide a model for Plasmodium-Pneumococcal coinfection which can be used 
to identify factors associated with the increased risk of invasive pneumococcal 
bacteremia/sepsis and where treatments and therapies can be designed and tested.  This 
chapter will describe two models of murine Plasmodium-bacterial (Listeria 
monocytogenes, and Streptococcus pneumoniae) coinfection used to examine the 
mechanisms by which innate immunity to bacterial infections is impaired during malaria.  
Using these models, I assessed the ability of IL-10 and HO-I activation to determine if 
these pathways that contribute to impaired control of NTS during malaria, also impact 
control of other bacterial infections. Finally, the duration of Plasmodium-driven 






Plasmodium yoelii infection results in long-term suppression of innate immunity during 
systemic bacterial coinfection 
In order to investigate Plasmodium-infection related immunosuppression and 
subsequent impaired immunity to bacterial coinfections, we began probing immune 
responses using a model bacterium, Listeria monocytogenes (Lm) ΔactA mutant strain, 
which is attenuated due to the deletion of the virulence factor gene that allows actin 
polymerization-dependent intracellular mobility and the ability to spread from cell to cell 
[100].  While Lm is not a common bacterial infection seen in coinfections during malaria, 
it is useful due to the vast amount of knowledge about its interaction with innate and 
adaptive immune responses.  Thus, the creation of a malaria-bacteria coinfection model 
with Lm provided an insightful means to probe a predictable and well-characterized 
infection system. The readout of bacterial burdens in form of colony forming units (cfu) 
from spleens and livers at time points ranging 1 to 3 days post Lm infection presents a 
quantitative way to evaluate the quality of the innate immune response to a bacterial 
infection. 
To examine Plasmodium-induced suppression of innate immunity during systemic 
bacterial infection C57BL/6N mice were first infected with Plasmodium yoelii 17XNL 
(Py), which resulted in increasing parasitemia through about three-weeks post infection 
that was followed by resolution of the infection during the ensuing week (Fig. 4A). 
Control and Py-infected mice were subsequently infected, via intravenous injection, with 
Lm ΔactA 7-days post Py infection. Clearance of Lm was delayed, in particular in the 
spleen, in Py-infected mice compared to control mice (Fig. 4B). To examine Py-induced 
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suppression over the course of Py-infection, mice were infected with Lm on day 7, 14, 
and 28 post-Py infection and spleens were removed 2-days later to quantify Lm burden. 
Throughout the course of Py infection, mice had elevated bacterial burdens (Fig. 4C).  
Remarkably, impaired innate immunity to Lm was also observed at both one-month (day 
63) and two-months (day 98) post-Py infection (Fig. 4C). Collectively, these data 
demonstrate that Py suppresses the innate immune response during systemic bacterial 
infection with Lm, including time points well beyond resolution of the Py infection. 
 
Figure 4. P. yoelii infection induces long-term suppression of anti-bacterial innate immunity during 
bacteremia. A) C57BL/6N mice were infected with 105 Py pRBCs. Percent parasitemia (percent of RBCs 
infected with Py) was evaluated during the course of infection. Data (meanS.D.) are from 9 mice and 
representative of 3 independent experiments. B) C57BL/6N mice were infected with 105 Py pRBCs, seven 
days later both control and Py-infected mice were infected with 5x106 CFU Lm ΔactA. Lm burden was 
determined in the spleen and liver on days 2, 3, 6, and 9 post-Lm infection. Data are cumulative results 
from two-independent experiments with 3 or 6 mice per group per time point. Each symbol represents an 
individual mouse. Data were analyzed by two-tailed Fisher’s exact test. LOD = limit of detection. 
[cfu/spleen day 11 (4) data was originally published in The Journal of Immunology. White C.E., Villarino 
N.F., Sloan S.S., Ganusov V.V., and Schmidt N.W. 2015. Plasmodium Suppresses Expansion of T Cell 
Responses to Heterologous Infections. J. Immunol. 194: 697-708. Copyright © 2015 The American 
Association of Immunologists, Inc.] C) C57BL/6N mice were infected with 105 Py pRBCs. On days 7, 14, 
28, 63, and 98 post-Py infection both Py-infected and control mice were infected with 5x106 CFU Lm. 
Bacterial burdens were determined 2 days post Lm infection. Data (meanS.E.) are cumulative results from 
2- to 3-independent experiments with 4 to 9 mice per group. Data were analyzed with Mann-Whitney test, 




Py infection impairs IFNγ production in response to ΔactA Lm during parasitemia, but 
enhances Lm induction of IFNγ after parasite clearance. 
 IFNγ is an important inflammatory cytokine produced during Plasmodium 
infections that activates innate immune cells to enhance anti-parasite functions, such as 
uptake and killing of infected RBCs and enhance production of other inflammatory 
signals to amplify the immune response [101, 102].  There is an early burst of IFNγ, 
produced primarily by natural killer T-cells (NK), and to a lesser degree, CD4+ T cells, in 
the early days of a blood-stage infection [103, 104].  There is also an induction of 
immunosuppressive factors such as IL-10 that functions to prevent immunopathology 
associated with the production of inflammatory cytokines, which can also suppress the 
overall immune response. It is also well established that IFNγ signaling is paramount in 
initiating an effective immune response to Lm infection [105]. 
  To test whether Py infection impairs the production of IFNγ in response to 
secondary ΔactA Lm infection, mice were either challenged with Py followed by Lm 7 
days later or only Lm.  Serum was collected from peripheral blood before Lm infection 
(day 7 post Py) and both spleens and serum were collected 24 hours after i.v. Lm 
infection.  Prior to Lm infection, baseline levels of IFNγ were detected in either 
coinfected or Lm only infected mice.  One day after Lm infection, however, coinfected 
mice had significantly lower levels of IFNγ in both whole spleen homogenate and in 
serum (Fig. 5 A).   
Since we already observed that Py-infected mice had an impaired ability to 
eliminate Lm infection up to 2 months after parasite clearance (Fig. 4C), we sought to 
examine whether or not IFNγ production in response to Lm was reduced in coinfected 
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mice at this late timepoint post Py infection.  Unlike the Py-induced suppression of IFNγ 
seen when Lm infection was initiated 7 days post Py, when Lm infections began 100 days 
post Py, levels of IFNγ in serum of coinfected mice were significantly higher than mice 
receiving only Lm both 1 and 2 days after Lm infection.  A similar trend was seen in 
spleens 2 days post Lm (Fig. 5B).  These results suggest that although IFNγ production is 
limited in Py-infected mice during acute parasitemia, the response to Lm infection 
becomes primed at later timepoints and able to produce a more robust IFNγ burst.  
 In order to determine the degree to which the lack of IFNγ production contributed 
to the inability of coinfected mice to clear Lm at early time points, IFNγ activity was 
blocked in coinfected mice and mice infected with Lm only.  C57BL/6 mice were 
infected with Py and given i.p. treatments of either anti-IFNγ antibody or isotype control 
8 hours prior to Lm infection and additional treatments 24- and 48-hours post Lm.  
Spleens and livers from these mice were then collected 3 days post Lm (day Py+10).  
Analysis of bacterial burdens showed that blocking IFNγ in Lm only mice did not impair 
clearance from spleens (Fig. 6C).  In an alternative approach, coinfected mice received 
treatments of recombinant IFNγ via i.p. injection 8 hours prior to Lm infection on day 7 
post Py as well as 24- and 48-hours post Lm.  Spleens and livers from these mice were 
then collected 3 days post Lm (day Py+10), while coinfected and Lm only infected 
mouse groups received no treatment.  Treating coinfected mice with recombinant IFNγ 
did not improve Lm clearance in the spleen or liver (Fig. 4D).  In a single experiment 
(shown in Figure 5E), coinfected mice given wildtype Lm did not appear to have as 
significant of a decrease in serum IFNγ 1 day after Lm infection compared to what was 
observed with in the Py coinfection with the ΔactA mutant (Fig. 5A and B) and had 
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similar IFNγ levels as mice that received wildtype Lm alone by 2 day post Lm infection 
(Fig 5E).  Together, these results do not support the hypothesis that the Py-infection 
induced decrease in IFNγ production in response to Lm infection plays a major role in the 















Figure 5.  IFNγ production during early and late coinfection. (A,C-D)C57BL6 mice were infected with 
105 Py pRBCs followed by 5x106 cfu Lm on days indicated in figure. A) Serum was collected via retro-
orbital bleeds 7 days post Py infection, prior to ΔactA Lm infection, and both serum and spleens were 
collected 24 hours after Lm infection (day Py+8).  B and E) Mice were infected with Lm 100 days post Py 
infection, or Lm wt on day Py+7.  Serum was collected 1- and 2-days post Lm and spleens were harvested 
2 days post Lm (day Py+102) B), day Py+9 E).  IFNγ concentrations from serum and spleen homogenate 
were determined with ELISA. C) Mice were treated with anti-IFNγ monoclonal antibody 8 hours prior to 
Lm infection and 1- and 2-days post Lm D) Mice were treated with recombinant IFNγ 8 hours prior to and 
1- and 2- days after Lm infection. C-D)  or wildtype Lm (E). Tissues were collected for cfu analysis day 3 
post Lm Data are mean S.D. (A, C,-D) and are from a single independent experiment that represent 2-3 
repeated experiments.  Data in B. are meanS.E. and are cumulative results from 2 independent 
experiments. Data in E are mean  S.D from only one experiment.  Statistics are One-Way ANOVA with 













Py infection improves clearance of wild-type Lm with functional actin polymerization 
ability 
Our initial observations with the Py+Lm coinfection model were made with an attenuated 
mutant strain of Lm that is lacking the actA gene, which is involved in the  ability of Lm 
to polymerize actin and is a major virulence factor that allows Lm to invade nearby cells 
and evade the immune system [100, 106].  One advantage of using the attenuated ΔactA 
mutant was due to the higher inoculum that can be delivered to mice through intravenous 
injection without producing a lethal infection, allowing injections of 5x106 cfu rather than 
104 cfu of wildtype Lm that is consistently lethal in C57BL/6 mice [107].  In order to 
determine whether the impaired clearance of Lm following Py infection was dependent 
on a functional actA gene in Lm, C57BL/6 mice were infected with Py followed by 
infection with 104 cfu i.v. wildtype Lm 10403S 7 days later.  Control mice received only 
the wildtype Lm infection. Two days after bacterial infection spleens and livers were 
collected from Lm only and Py+Lm coinfected mice and bacterial burdens were assessed.  
Surprisingly, when using virulent Listeria, coinfected mice had drastically lower bacterial 
burdens in the spleen than mice that received wildtype Lm alone (Figure 5A).  While 
these results raised interesting questions pertaining to Listeria biology and how the ability 
to polymerize actin and escape from the intercellular space of a cell or invade 
neighboring cells impacts outcome of Listeria during coinfection with Py, these ideas 






Figure 6. Py infection confers protection against wildtype 
Lm.  C57BL/6 mice were infected with 105 Py pRBCs followed 
by 5x106 cfu wildtype Lm 7 days later.  Serum was collected 24- 
and 48- hours post Lm infection via retro-orbital bleed and 
spleens were collected 2 days post Lm  Data (meanS.D.) are 
from a single independent experiment that represent 3 
independent experiments.  Statistical analysis was performed 






Contribution of P. yoelii-induced HO-1 and IL-10 to impaired innate immunity is 
bacteria-dependent 
 Previous studies have identified mechanisms by which Plasmodium suppresses 
immunity to NTS [59, 61, 62, 108, 109].  Currently, nearly all mechanistic investigations 
of impaired immunity to non-Typhoid Salmonella (NTS) coinfections during malaria 
have built upon the key findings that the activities of HO-1 and IL-10, which are 
produced during active Plasmodium infection, play an important role in the increased 
severity of bacterial infection [59, 62].  Plasmodium infections result in the release of 
heme, which activates HO-1. HO-1 induces the release of immature granulocytes that 
exhibit impaired oxidative burst in response to PMA stimulation [61]. Additionally, 
Plasmodium infections induce myeloid cells to produce IL-10 that impairs control of 
NTS infection [59]. To determine whether those mechanisms of impaired immunity to 
bacterial coinfections are specific to NTS coinfections, we first confirmed the results of 
those studies by infecting mice with P. yoelii followed by coinfection with NTS. As 
shown before, P. yoelii-infected mice treated with tin protoporphyrin IX (Sn PP; a 
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synthetic heme analog that inhibits activity of HO-1) or an anti-IL-10 monoclonal 
antibody had reduced bacterial burdens compared to the respective control treated mice 
(Fig.7 A and B).  Contrary to observations in NTS coinfections, Sn PP treatment did not 
improve anti-bacterial immunity in Py+Lm (Fig. 7C) co-infected groups, as bacterial 
burdens of Sn PP treated mice were comparable to control treated groups. Blocking IL-10 
with an anti-IL-10 monoclonal antibody treatment prior to Lm infection also did not 
improve bacterial clearance in co-infected mice (Fig. 7D).  These data show that our use 
of Sn PP and anti-IL-10 antibodies to block activity of HO-1 and IL-10, respectively, is 
valid in our model of Py bacterial coinfections since we have shown the same trend as 
Cunnington et al. replicated data from Lokken et al. with the same strain of NTS [59, 62].  
The data also show that unlike in NTS coinfections with Py, HO-1 and IL-10 do not play 
a role in the impaired antibacterial immunity in Lm+Py coinfections.  Together, this 
suggests that there may be other mechanisms by which Plasmodium infection induces 










Figure 7. Py induction of HO-1 and IL-10 impair immunity to NTS but not Lm C57BL/6N mice were 
infected with 105 Py pRBCs, ten days later both control and Py-infected mice were infected via 
intraperitoneal injection with 103 CFU Salmonella enterica serovar Typhimurium (NTS). Spleen, liver, and 
peripheral blood bacterial burdens were determined day 2-post NTS infection. Mice were treated with tin 
protoporphyrin IX (Sn PP) or PBS control at 48, 24 and 8 hours before NTS infection and 18 hours post-
NTS infection (A), or anti-IL-10 antibody or IgG isotype control on days 9, 10, and 11 post Py (B). Data 
(meanS.D.) are representative of two independent experiments with 5 mice per group (A) or are from a 
single experiment with 5 mice per group (B). C-D) C57BL/6N mice were infected with 105 Py pRBCs, 
seven days later both control and Py-infected mice were infected with 5x106 CFU Lm. Spleen and liver 
bacterial burdens were determined day 2-post Lm infection. Mice were treated with tin protoporphyrin IX 
(Sn PP) or PBS control at 48, 24 and 8 hours before Lm infection A), or IL-10 antibody or isotype control 
on days 6, 7, and 8 post Py B). Data (meanS.E.) are cumulative results from two independent experiments 
with 3 to 6 mice per group analyzed with one-way ANOVA followed by Tukey’s multiple comparisons 
test.   
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 Plasmodium yoelii infection suppresses innate immunity to Streptococcus pneumoniae 
 
 (Sp) is one of the most common bacteria observed in individuals co-infected with 
malaria and an invasive bacterial infection [42, 45]. To formally test the ability of 
Plasmodium to impair innate immunity to Sp, mice were infected with Py followed by 
intranasal Sp infection 7-days later. Following infection, diplococci were clearly evident 
in the blood of co-infected mice (Fig. 8A), which showed lower survival through 84-
hours post Sp infection compared to control Sp-only infected mice (Fig. 8B). 
Surprisingly, there was no difference in Sp burdens 3-days post-infection in the lungs of 
Py-infected and control mice (Fig. 8C), suggesting that Py infection does not impair 
colonization of Sp in the lung. In contrast to the lung, and consistent with the decreased 
survival of Py-infected mice following Sp infection, there were substantial increases in 
Sp burden in both the blood (Fig. 8D) and spleen (Fig. 8E). These data demonstrate that 











Figure 8. P. yoelii infection increases severity of Pneumococcal infection. C57BL/6N mice were 
infected (i.v.) with 105 P. yoelii infected RBCs, 7-days later Py-infected and naïve mice were infected (i.n.) 
with 106 CFU Streptococcus pneumoniae (Sp). A) Giemsa stained blood smear from co-infected mouse. 
Arrows indicate Sp diplococci, arrow heads indicate P. yoelii infected RBCs. B) Survival of mice following 
Sp infection. Data are pooled results from 4 independent experiments with a total of 21 Sp only mice and 
25 Py+Sp co-infected mice. Survival data was analyzed by log-rank (Mantel-Cox) test. C-E) Mice were 
sacrificed at either day 3 post Sp infection (10 days post Py infection) or when mice became moribund. Sp 
burden was quantified in lungs (C), blood (D), and spleen (E). (C-E) Data (meanS.D.) are from a single 















Py infection induces long-term impaired immunity to Sp infection. 
Similar to the long-term defect in innate immunity to Lm in mice following 
clearance of Py infection (Fig. 4C), mice infected with Sp, both 30 days-post Py infection 
(Fig. 9A-C) or 65-72 days-post Py infection (Fig. 9D-F), had increased bacterial burdens 
two days-post Sp infection in lungs, peripheral blood, and spleens compared to age 
matched mice infected with only Sp. These data demonstrate that Py infection also 
impairs the innate immune response to Sp bacteremia, and that the Plasmodium-driven 
susceptibility to Sp is prevalent beyond the duration of the parasite infection. 
 
Figure 9. Py infection induces long-term impaired immunity to Sp infection. C57BL/6N mice were 
infected with 105 P. yoelii infected RBCs, then infected with 106 CFU Sp either 30 (F-H) or 65-72 (I-K) 
days later. Sp bacterial burdens in blood and organs were obtained from mice sacrificed 2 days after Sp 
infection. (F-H) Data (meanS.D.) representative of 2 independent experiments with 5 to 7 mice per group. 
(I-K) Data (meatS.E.) cumulative results from 2 independent experiments with 7 to 10 mice per group. 
(C-K) Dotted lines indicate limit of detection. Each symbol represents a single mouse. Statistical 






P. yoelii-induced IL-10 contributes to impaired resistance to Pneumococcal coinfection 
 Since HO-1 and IL-10 have been found to impair innate immune responses in the 
context of malaria coinfections with NTS, we explored the possibility that these factors 
also contribute to the impaired resistance to Sp that we have observed in our Py 
coinfection model system. Contrary to observations in NTS coinfections, Sn PP treatment 
did not improve anti-bacterial immunity in Py+Sp co-infected mice (Fig. 10A), as 
bacterial burdens of Sn PP treated mice were comparable to control treated groups. 
Blocking IL-10 with an anti-IL-10 monoclonal antibody treatment prior to Lm infection 
did not improve bacterial clearance in co-infected mice (Fig. 7B).  Similar to NTS (Fig. 
7B) while in contrast to LM (Fig. 7D), anti-IL-10 monoclonal antibody treatment in 
Py+Sp co-infected mice was sufficient to significantly reduce the severity of 
Pneumococcal infection compared to control IgG treated Py+Sp mice (Fig. 10B). These 
data demonstrate that Plasmodium-induced IL-10 is part of the mechanism by which Py 
infection impairs control of Sp.  The data from our explorations of both the Py+Lm and 
Py+Sp coinfection model systems indicate that there may be additional mechanisms by 





Figure 10. IL-10 derived from Py infection impairs immunity to Sp. C57BL/6N mice were infected 
with 105 Py pRBCs, eight days later both control and Py-infected mice were infected i.n. with 5x105 CFU 
Sp. Lung, spleen, and peripheral blood bacterial burdens were determined day 2-post Sp infection. Mice 
were treated with tin protoporphyrin IX (Sn PP) or PBS control at 48, 24 and 8 hours before Sp infection 
and 24 hours post Sp infection A), or IL-10 antibody or isotype control on days 6, 7, and 8 post Py B). 
Data (meanS.E.) are cumulative results from two independent experiments with 5 mice per group and 
analyzed with one-way ANOVA followed by an uncorrected Fischer‘s LSD test with multiple 











Complications associated with bacterial coinfections during malaria have been the 
subject of numerous clinical reports.  Several basic scientific studies have reported 
mechanisms by which Plasmodium infections impact susceptibility to invasive bacterial 
infections, but these have exclusively focused on suppressed immunity to NTS.  A broad 
range of bacterial pathogens are isolated from bacteremic patients with malaria, yet, other 
than what is known about NTS coinfections, very little is known about the mechanisms 
that cause increased risk for invasive bacterial diseases during malaria.  Identifying 
specific or more general deficiencies in innate immune responses during Plasmodium 
infections that are responsible for diminished bacterial immunity is necessary to improve 
the treatment of these cases.  In this project, we sought to create tools that could be used 
to explore the underlying mechanisms of malaria-induced immune suppression and 
investigate what factors contribute to impaired innate immunity to invasive bacterial 
infection during acute Plasmodium infection and during convalescence.  Prior reports on 
NTS infections during malaria, demonstrated that infection-induced IL-10 production and 
infection-induced hemolysis, and activation of HO-1, were central to impaired immunity 
to NTS.  Here, we have demonstrated that Plasmodium infections also impair innate 
immunity to bacterial infections independent of HO-1 and IL-10.  By establishing 
coinfection model systems with Lm and Sp, we have found that this defect in immunity 
to secondary bacterial infection extends beyond clearance of the parasite and that the 




It has been postulated that Plasmodium-induced immune suppression and 
susceptibility to invasive bacterial infections is not attributed to a parasite-specific factor, 
but rather is due to Plasmodium-induced hemolysis, and subsequent activation of HO-1 
[109].  Additionally, Cunnington and colleagues demonstrated that neutrophils collected 
from patients previously infected with Plasmodium falciparum had defective ROS burst 
following PMA stimulation that lasted up to 8 weeks-post treatment [61].  Another recent 
clinical investigation found decreased cellular- and serum- mediated bacterial(NTS) 
capacity in Malawian children with current or convalescent P. falciparum malaria [64].  
This long-term Plasmodium-driven defect in NTS immunity was attributed to impaired 
opsonophagocytic activity and contributed to decreased PMN production of reactive 
oxygen species (ROS) following stimulation with serum-opsonized NTS.  We 
demonstrate that Py-induced immune suppression lasts up to 2-months post clearance of 
Py, when the effects of hemolysis are likely no longer in play. Of note, tissue deposition 
of hemozoin byproducts from P. berghei infection remains deposited in liver, bone 
marrow, and spleen tissues as well as within isolated CD11b+ cells isolated from those 
tissues and peripheral blood of mice for at least 196 days post infection [110].  The 
contribution of hemozoin as a factor involved in Plasmodium-dependent suppression of 
anti-bacterial immune functions will be revisited in Chapter IV. 
In our examination of the impact of Plasmodium infection on production of an 
inflammatory cytokine, IFNγ, we observed that the capacity of IFNγ production in 
response to Lm infection was dependent on the amount of time post Py infection that 
mice were infected with Lm (Fig. 6A and B).  Py+Lm coinfected mice responded with 
lower production when Lm infection began 7 days post Py infection compared to mice 
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only receiving Lm.  Surprisingly, the opposite was true when the Lm infection occurred 
100 days post Py infection, as we found higher levels of IFNγ in serum and spleens of 
coinfected mice.  The data in this set of experiments may suggest that Py infection may 
induce a state of hyperresponsive “trained immunity”, where the Plasmodium infection 
induces an innate immune “memory” that increases responses to a secondary infection 
[111].  The concept of innate immune memory refers to a hypo- or hyperresponsive state 
that occurs in innate immune cells where they are primed by an initial stimulus to 
respond in an extreme manner [111].  Several previous studies have demonstrated data 
that support the idea of trained immunity in malaria.  Schrum et al. showed that in vitro 
treatment of healthy human PBMCs with synthetic hemozoin or P. falciparum infected 
RBCs, and also cells from Kenyan children with febrile malaria, were hyperresponsive in 
response to TLR2 stimulation in an IFNγ independent manner [112].  Another study 
describes hyperresponsive of human PBMCs and murine splenocytes from P. falciparum 
or P. chabaudi infected individuals, respectively, that was dependent on TLR9, MyD88, 
and to a greater extent IFNγ-signaling [113].   
The hyperresponsiveness of innate immune cells in the context of malaria has also 
been attributed to the increased susceptibility to secondary bacterial infections.  One 
study tested responses of PBMCs from febrile malaria patients and observed that malaria-
primed cells produced pathological amounts of IL-1β following stimulation with LPS, 
modeling a secondary bacterial “superinfection” [114].  In this study IFNγ was required 
for inflammasome activation and IL-1β production in P. chabaudi infected mice and 
treatment of these mice with IL-1 receptor agonist (IL1RA) improved their survival 
following intragastric infection with NTS.  Given the range of results in studies that focus 
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on the immunomodulatory role of IFNγ in malaria, it is unclear whether this or other 
cytokines are dispensable for the induction of trained immunity [112].  While hyper 
responses were seen in studies with P. chabaudi + NTS coinfection and P. chabaudi + 
LPS challenge where observations were made 7 days post Plasmodium infection, our 
challenge of Py-infected mice with Lm 7 days post Py did not have a greater IFNγ 
response to Lm than mice infected with Lm alone.  Alternatively, when the Lm infection 
began 100 days post Py infection in our Py+Lm coinfection model, we did see that the 
innate immune response of coinfected mice was primed to respond with a greater level of 
IFNγ than Lm only mice.  Our data therefore suggests that Plasmodium infection induces 
trained innate immunity (at least) after the initial acute phase of the blood stage of 
malaria, and that this affect lasts long (up to 2 months) after clearance of the parasite.   
By blocking the activity of IFNγ with an anti-IFNγ antibody and comparing 
bacterial burdens in spleens of Lm infected treated and untreated mice to Py+Lm 
coinfected mice, we were able to determine whether the impaired IFNγ response 
following Lm infection that we observed in Py-infected mice during the early stage of 
parasitemia (7 days post Py) contributed to their delayed clearance of Lm from spleens 
(Fig. 6C).  In another experiment recombinant IFNγ was given to coinfected mice to test 
whether providing exogenous IFNγ would improve their ability to clear Lm.  We found 
that neither the intervention of blocking IFNγ activity in Lm only mice nor the addition 
of recombinant IFNγ to coinfected mice changed their abilities to clear Lm from spleens 
as compared to their respective control groups. Hence, during the early blood stage of 
malaria the impaired IFNγ production in response to a secondary bacterial infection does 
not appear to play a role in the suppressed antibacterial innate immunity in this model.  
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This finding is in agreement with our data showing a decreased IFNγ response to Lm 
infection early in Py infection but heightened IFNγ long after Py clearance.  If IFNγ were 
involved in the delayed clearance of Lm in coinfected mice, we would expect IFNγ 
responses to be similar at both timepoints post Py infection.  Additional experiments are 
required to understand the underlying mechanisms and kinetics of both the impaired 
production of proinflammatory cytokines during Plasmodium infections as well as the 
hyperresponsive, “trained” innate immunity that occurs in the time following clearance of 
the parasite.  There is also strong rationale to examine how repeated Plasmodium 
infections in individuals over time may affect these occurrences, and whether they have a 
detrimental impact on host immunity to other bacterial pathogens, such as NTS and Sp.  
Clinical reports of invasive bacterial disease coinciding with malaria often report 
both NTS and Sp as the two organisms most commonly isolated from blood. 
Experimental studies to date have focused almost exclusively on NTS and it is unknown 
whether the mechanisms of Plasmodium-induced immune suppression to NTS will be 
important for Sp or other bacterial pathogens found in coinfections with malaria (e.g., 
Haemophilus influenzae, Mycobacterium tuberculosis, Staphylococcus aureus, 
Streptococcus pyogenes, etc. [42-49, 54]). We report for the first time, to our knowledge, 
a murine Plasmodium and pneumococcal coinfection. Mice were infected with 
Plasmodium yoelii 17XNL followed by a Streptococcus pneumoniae ATCC #6303, a 
type 3 capsule serotype strain, via the natural intranasal route. Consistent with the risk of 
invasive Sp infections in humans with malaria [42], we found decreased survival and 
increased bacterial burdens in co-infected mice compared to control Sp only infected 
mice (Figure 8).  Further work is required to achieve a better understanding of the factors 
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at play in this coinfection.  Future efforts should examine different serotypes of Sp, as the 
pathogenicity of Sp is highly variable in many disease models and to suggest that ATCC 
strain #6303, or even that type 3 capsule Sp represent all Sp would be an overstatement 
[115]. 
The impact of hemolysis-related immune suppression initiated by Plasmodium 
infection (activation of HO-1 and IL-10) has been well studied in the context of NTS in 
both animal models and clinical studies [59, 61, 109]. By exploring coinfection models 
with different bacterial pathogens during malaria, we sought to determine whether the IL-
10-dependent and HO-1-dependent mechanisms were specific to NTS coinfection, or if 
they also play a role in malaria-related immunosuppression to other bacterial 
coinfections. While our results indicated that HO-1 inhibition with Sn PP failed to 
improve immunity to either Lm or Sp coinfections (Fig. 4C and Fig. 7A), we did see a 
reduction in Sp bacterial burdens in co-infected mice treated with anti-IL-10 (blocking) 
antibody (Fig. 7B). This result is in line with observations made in influenza and 
pneumococcal coinfections, where IL-10 production following influenza virus infection 
disrupts the inflammatory response to Sp in a manner that favors dissemination and 
invasive disease [116]. Blocking IL-10 activity in the Py+Sp coinfection may, similarly 
to what is seen in the influenza coinfection [116], results in increased levels of 
inflammatory factors in the respiratory tract, such as TNFα and IFNγ, enhanced PMN 
infiltration to lungs, and restore the antibacterial immune response to Sp to normal. IL-10 
is known to impair neutrophil chemotaxis, which may contribute to “neutrophil paralysis” 
that has been characterized in samples from patients with P. vivax malaria [117]. Thus, 
the anti-IL-10 treatments may have restored neutrophil function, resulting the reduction 
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in pneumococcal burden in anti-IL-10 treated co-infected mice compared to isotype-
treated controls. While this result shows that IL-10 is involved in suppressing the immune 
response to Sp during Py infection, it likely does not explain the long-term impaired 
immunity to Sp we have demonstrated (Fig. 6), since levels of IL-10 decrease following 
parasite clearance [118].  
Curiously, we found that defective immunity to Lm following Py infection 
occurred only with the ActA-deficient mutant strain, while wildtype Lm 10403S was 
cleared more efficiently in coinfected mice (Fig. 5A).  Since the strain used exclusively 
while characterizing the model also expressed chicken ovalbumin protein (OVA) allows 
for measurement of Lm-OVA-specific T-cells and quantitative assessment of adaptive 
immune response (also used in C. White et. al [119]), an actA-deficient strain that does 
not express OVA was also tested in the coinfection model prior to testing wildtype Lm.  
In vivo clearance of this OVA-negative, actA-deficient strain was impaired in coinfected 
mice similarly to the OVA-expressing strain used in the majority of this study (data not 
shown), suggesting that differences in immune-clearance and effect of Py infection are 
dependent on the presence of functional actA gene expression 
Based on this biological difference of actA-positive and actA-negative Lm, it is 
possible that factors such as opsonizing complement factors involved in 
opsonophagocytosis, are absent or are rendered inactive or defective by Py infection and 
therefore unable to function normally against actA-negative Lm that invades new cells 
from extracellular space [120].  This deficiency would have no negative consequence for 
Lm that invades new cells mainly via direct intercellular actin-propulsion into nearby 
cells.  In this scenario, the inflammatory nature of the Py infection may help to activate 
51 
 
innate immune cells to enhance their ability to kill intracellular Lm that is unable to 
escape via function of actA.  Combined with less reliance on evading extracellular 
immune components (due to their limited time spent outside of cells compared to actA-
deficient Lm), enhanced killing by the Py-induced inflammatory response may explain 
the improved wildtype Lm clearance during coinfection that is contrary to the defective 
clearance observed in Py+actA-deficient Lm coinfection.   
The result that demonstrated enhanced clearance of wildtype Lm conferred by Py 
infection is interesting, highly repeatable and further exploration of the mechanisms 
behind Py infection-mediated protection could uncover potential therapies for invasive 
Lm disease.  For the scope of this project, however, continuing to pursue mechanisms in 
Listeria biology behind the actA-dependent defective clearance in Py coinfection would 
be tangential and not helpful in our pursuit of understanding Plasmodium-driven 
immunosuppression related to impaired to invasive bacterial coinfection.  For this reason, 
wildtype Lm is not used experimentally or investigated in the Py coinfection model for 
the remainder of the project. 
These findings provide a translational picture of malaria-driven long-term defects 
in anti-bacterial innate immunity, where we have observed Py-driven impaired immunity 
to Lm and Sp coinfections at all time points examined, including more than two months 
after clearance of infected red blood cells.  Furthermore, these data indicate that the 
immune suppression occurs independent of Py-induced hemolysis, given that the duration 
of hemolysis and related physiology during malaria is limited to the active blood stage of 
the infection and effects of hemolysis return to normal relatively quickly.  For instance, 
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HO-1 activity significantly decreases in Py infected mice five days after antimalarial 

































IMPACT OF PLASMODIUM YOELII INFECTION ON SPLENIC MYELOID CELL 





The spleen, splenic innate immune cells, and their roles in infection 
Plasmodium infection induces a robust inflammatory immune response 
characterized by substantial production of inflammatory cytokines, the effects of which 
are eventually regulated by anti-inflammatory factors in order to reduce collateral 
damage to host tissues in the process.  Several organs are damaged during Plasmodium 
infection, including the liver, kidneys, lungs, brain, bone marrow and spleen.  There is 
sufficient reason to believe that pathology of the spleen during Plasmodium infection is 
particularly important in the context of invasive bacterial infection.  Under normal 
conditions, the spleen is responsible for clearance of senescent and damaged erythrocytes 
and other debris [122].  Another critical function of the spleen is to clear pathogens that 
have entered the blood stream.  This is achieved by strategically positioned macrophages 
that internalize and kill circulating pathogens. By residing in close proximity to the 
marginal zone and the small, open ended capillaries of the penicillar arteriole [47], 
marginal zone macrophages (MZM), and marginal metallophilic macrophages (MMM) 
function as scavenger phagocytes patrolling the marginal zone space for pathogens and 
54 
 
other cell debris.  MZMs can interact directly with MZ B cells while MMMs can enter 
the white pulp of the spleen and present antigen to DCs in the marginal zone [123, 124].  
From the marginal zone, approximately 10% of circulating blood flows slowly through 
the perifollicular zone to the reticular meshwork of the red pulp, and here damaged 
erythrocytes, debris, and blood borne pathogens can also become stuck and internalized 
by red pulp macrophages (RPM) [38].  These specific subsets of tissue-resident 
macrophages are equipped with a unique set of recognition receptors that allow them to 
efficiently identify, uptake, and kill invading pathogens. 
The role of these splenic tissue-resident macrophages during blood-borne 
infections is well characterized for several pathogens.  A direct recognition of Sp capsule 
polysaccharide by SIGNR-1(CD209b), a C-type lectin receptor which is highly expressed 
on MZMs, is involved in uptake of Sp and has been demonstrated to be critical for 
protection of mice against pneumococcal septicemia [125, 126].  SIGNR-1 also interacts 
with components of the complement cascade to promote protection vs. pneumococcal 
septicemia by binding C1q and initiating C3-convertase, initiating an Ig-independent 
activation of the classical complement pathway [127]. MZMs also express a scavenger 
receptor, MARCO, which is known to recognize gram negative bacteria and works in 
concert with toll-like receptor signaling to facilitate cell activation and enhanced 
phagocytosis functions [128, 129].  MARCO, unlike SIGNR-1, recognizes unopsonized 
pathogens [130].  Specific functions of MMMs during blood-borne infections have also 
been described, including early control of Lm infection independent of T- and B-cell 
interaction in a bacteremia model, antigen presentation and indirect activation of CD8+ T 
cells, and recognition and phagocytosis of blood-borne pathogens involving MOMA-1, a 
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surface molecule enriched on spleen MMMs [131, 132].  Like MZMs, RPMs have the 
ability to eliminate Sp in vivo [133].  This anti-pneumococcal ability of RPMs, however, 
was demonstrated in mice that were previously infected with Leishmania donovani where 
RPMs become more important in capture of blood-borne pathogens due to the 
Leishmania donovani-induced loss of MZMs.  A similar phenomenon occurs in 
Plasmodium chabaudi infection, where both MZMs and MMMs are nearly completely 
lost at the height of parasitemia [134].  To what degree these splenic macrophage 
populations are loss following Py infection and the effect that potential loss may have on 
control of bacterial coinfections are not known. 
One of the key indicators of a Plasmodium infection, in addition to measurable 
fever, is splenomegaly that is often diagnosed by clinicians when the spleen is palpable at 
least 10 cm below costal margin of the patients thoracic cage [135].  Splenomegaly 
during malaria, also referred to as hyper-reactive malarial splenomegaly syndrome 
(HMS), is the result of constant stimulation with parasite antigen during blood stage of 
malaria .  Plasmodium-specific antibodies, especially IgM, aggregate in the form of 
immune complexes to drive HMS pathology [136].  Other byproducts of the heavy 
parasite burden in the spleen includes deposition of large amounts of malarial pigment 
(hemozoin), and destruction of splenic architecture that is important in maintaining 
normal physiological functions and innate and adaptive immune functions in context of 
infections [123, 134, 137].  Since the spleen is the primary organ involved in filtration of 
blood and cleanup and turnover of erythrocytes and cellular or foreign debris (i.e. blood-
borne microbes), the spleen and the specialized phagocytic cells have several critical and 
direct roles in controlling the blood stage of Plasmodium infections.  For this reason, 
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spleen/splenic macrophages during Plasmodium infection has been the subject of many 
previous studies.  During blood stage malaria parasitized and damaged erythrocytes, as 
well as other parasite and cellular debris are filtered out circulation by RPMs [39]. 
Based on the clear evidence that destruction and architectural disruption of the 
marginal zones occurs in the spleen following Plasmodium infection, it has been 
hypothesized that this decreases overall functional ability of the spleen to perform its role 
in defense against a blood-stream bacterial infection [47, 134, 137, 138].  Splenomegaly 
and loss of both marginal zone macrophages (MZMs) and metallophilic macrophages 
(MMMs) occur in spleens of malaria patients who have increased risk to invasive 
bacterial infections [47].  Subsets of splenic macrophages serve as sentinels and provide 
clearance of blood-borne bacterial infections [39].  The importance of these cell types has 
been well documented in connection to resistance to blood-stream infections with 
Streptococcus pneumoniae, Listeria monocytogenes, Escherichia coli, and Salmonella 
typhimurium [125, 139].  Experiments utilizing low dose clodronate liposome treatments 
do deplete MMMs and MZMs have further demonstrated the importance of these cells 
based on the impaired survival of clodronate treated mice compared to untreated control 
mice following infection with sub-lethal Lm infection [131].  The observation that 
MMMs and MZMs are lost during Plasmodium chabaudi infection led us to the 
hypothesis that a similar loss or decrease in these cells in the spleen following Py 
infection may be contributing to the impaired clearance of Lm and increased 
susceptibility of Sp we have described in coinfection models in Chapter II [134].  This 
Chapter will explore this hypothesis. 
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 In addition to tissue resident macrophages in the spleen, innate immune cells that 
are recruited from circulation also play essential roles in controlling bacteremia in both 
Lm and Sp infections [140-142].  Considering our data showing increased Lm and Sp 
burdens in spleens of Py-coinfected mice compared to control mice receiving only 
bacteria, we also examined the possibility that Plasmodium infection changes numbers 
and proportions of these cells over the course of Py infection.  Robust inflammatory 
responses at the onset of the erythrocytic stage of Plasmodium infection activate the 
recruitment of neutrophils and “inflammatory” monocytes into circulation from the bone 
marrow where they contribute to the host control of parasite burden and induction of 
inflammation through production of cytokines [36, 143].  Clinical reports have found that 
increasing numbers of circulating neutrophils in infected individuals is positively 
correlated with parasite burden [144].  While monocytes are known to migrate to tissue 
sites of parasite sequestration [145], neutrophils do not seem to infiltrate such tissues 
despite systemic increases in chemokines [146]. The general lack of neutrophils in 
parasite loaded tissues is thought to be due to parasite-induced decreases in surface 
expression of CXCR2 or an increase in free heme and activity of heme oxygenase-1 [61, 
117, 146]. Both monocytes and neutrophils uptake and kill pRBCs by recognizing 
opsonins, such as complement factors or antibody-bound pRBCs [36, 47].  While 
parasite-specific IgG is not required for phagocytosis by monocytes, they enhance uptake 
and reduce risk of severe symptomatic malaria and complement is still needed in the 
absence of antibody [147, 148]. Monocytes and tissue resident macrophages (especially 
RPMs) also recognize unopsonized pRBCs through CD36, which also facilitates 
phagocytosis [149].   
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 There is also rational to suspect that Plasmodium infection induces faulty 
antimicrobial functions in monocytes and neutrophils.  Although they are critical in 
controlling parasite burden, studies describe defective phagocytosis functions of 
monocytes and neutrophils in patients with current or recent Plasmodium infection [36, 
64, 150].  Another observation has been made describing a decrease in cytokine 
production, such as TNF-alpha and IL-6, in LPS-stimulated monocytes from Malawian 
children with severe malaria [151].   
 One of the most effective mechanisms of cell-mediated clearance of both 
intracellular and extracellular microbial pathogens is the production of reactive oxygen 
species (ROS).  Through formation of ROS and its radical molecular dismutations, innate 
immune cells are able to directly damage and kill many pathogens and release pathogen 
associate molecular patterns (PAMPS) that can act as a signal for activation and 
recruitment of nearby cells [152].  As Plasmodium infections can alter spleen monocyte 
populations and impair the ability of phagocytic cells to produce ROS, both of which are 
important in the context of controlling blood-borne bacterial infections, we hypothesized 
that Plasmodium-dependent loss of monocytes and defective ROS production may be 
responsible for the impaired anti-bacterial immunity described in Chapter II. 
 The complement system acts as a critical innate immune defense against 
microbial infections by recognizing and labeling pathogens for both direct complement-
mediated killing and by enhancing the antimicrobial functions of phagocytic cells via 
opsonophagocytosis.  It is well documented that mice with dysfunctional complement 
factors or lacking components of the complement system have impaired immunity to 
bacterial infections, including Lm, Sp, and STm [57, 127, 153, 154].  Moreover, the 
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complement cascade is activated during Plasmodium infection through interactions with 
parasitized RBCs, leading to lower levels of serum C1q and defective complement 
activity compared to uninfected individuals [120, 155].  These findings led us to 
hypothesize that Plasmodium-induced functional defect of a serum component, such as a 
complement factor or opsonizing antibody, may contribute to impaired immunity against 
secondary bacteria coinfections.  This hypothesis will be considered while testing the 
ability of splenic phagocytes from Plasmodium infected mice to control intracellular 
bacterial replication in this chapter by infecting splenic phagocytes with Lm opsonized 
with serum collected from either naïve or Py-infected mice.  
 In this chapter, the total numbers of splenic myeloid cell types will be determined 
over the course of P. yoelii infection and up to 2 months after clearance of the parasite 
using flow cytometry.  Additionally, the overall control of intracellular Lm replication 
and the capacity of reactive oxygen species production of splenic phagocytes from Py 
infected mice will be assessed using a gentamicin protection assay and a flow cytometry-













Analysis of splenic myeloid cell population during Plasmodium yoelii infection and 
beyond parasite clearance 
 
 P. chabaudi infections disrupt splenic architecture and lead to the loss of 
marginal zone macrophages (MZMs) and marginal metallophilic macrophages (MMMs) 
[134].  As the spleen plays a vital role in the clearance of bacteria in the blood via these 
macrophage populations [125, 131, 156], it led to the hypothesis that Py infection results 
in a loss of these cell populations that contribute to impaired clearance of Lm.  To 
determine the impact of Py infection on splenic myeloid cell populations, mice were 
infected with Py and various days after infection spleens were removed for quantification 
of polymorphonuclear cells (PMNs), inflammatory monocytes, red pulp macrophages 
(RPMs), MZMs, and MMMs.  Cell types definitions are shown in Figure 11 as flow 
cytometry layouts describing our gating strategy.  As expected, the total cellularity of the 
spleen increased through resolution of Py infection, followed by a return to baseline at 
one- and two-months post clearance of Py (Fig. 12A).  Analysis of PMNs revealed a 
fairly consistent expansion in frequency (Fig. 12B) and total number (Fig. 12C) of PMNs 
at days 10, 30-33, and 65-67 post-infection. Whereas the frequency of inflammatory 
monocytes remained consistent between Py-infected and control mice (Fig. 12D), there 
was an increase in the total number of these cells at days 10 and 30-33 in Py-infected 
mice (Fig. 12E). The frequency of RPMs were lower in Py-infected mice at days 30-33 
and 65-67 post-infection (Fig. 12F), yet the total cell numbers remained fairly consistent 
during acute parasitemia and following resolution of infection (Fig. 12G). Consistent 
with the previous report [134], we observed a decrease in the frequency (Fig. 12H) and 
total number (Fig. 12I) of MZMs at days 30-33, 65-67, and 101-102 post-Py infection; 
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however, there was no difference in % of total splenocytes at day 10 post-Py infection.  
In contrast, the frequency (Fig. 12J) and total number (Fig. 12K) of MMMs remained 
fairly consistent following Py infection.  Although we did not expect changes in 
abundance of eosinophils or dendritic cells to have an impact on bacterial clearance, we 
included these cell types in our analysis to avoid misidentifying them as any of the other 
cells of interest (Fig. 13).   Collectively, there is no consistent increase or decrease in 
these cell populations that correlates with impaired clearance of Lm in Py-infected mice, 
suggesting that alternative mechanisms explain impaired anti-bacterial innate immunity 










Figure 11. Gating strategy for splenic myeloid cell populations.  
Single cell suspensions of spleens collected from mice infected with Py or age-matched naïve controls were 
prepared and stained with antibodies for flow cytometry analysis. Representative contour plots are from a 
naïve mouse. Arrows represent the hierarchical gating strategy that was used to determine the indicated cell 
populations. RPMs were gated early to avoid misidentification due to the highly auto-fluorescent nature of 


























Figure 12. P. yoelii-induced temporal changes in splenic myeloid cell populations do not correlate 
with impaired immunity during bacteremia. C57BL/6N mice were infected with 105 Py pRBCs. Spleens 
were collected from control or Py-infected mice on the indicated days post infection. A) Total numbers of 
cells per spleen on the indicated days. Myeloid cell populations were defined as follows: PMNs (CD3-, 
CD19-, F4/80-, SIGLEC-, CD11b+, Ly-6G+ ) (B-C), inflammatory monocytes (CD3-, CD19-, F4/80-, 
SIGLEC-, Ly-6G-, CD11b+, CD11c-, Ly-6Chi) (D-E), RPMs (CD3-, CD19-, F4/80hi) (F-G), MZMs (CD3-, 
CD19-, F4/80-, SIGLEC-, Ly-6G-, CD11b+, CD11c-, Ly-6Clo, CD209b-, CD169+) (H-I), MMMs (CD3-, 
CD19-, F4/80-, SIGLEC-, Ly-6G-, CD11b+, CD11c-, Ly-6Clo, CD169-, CD209b+ ) (J-K). B, D, F, J) Percent 
of splenocytes that are the indicated myeloid cell population. C, E, G, I, K) Total number of indicated 
myeloid cell population per spleen. Data (meanS.E.) are combined results from 1* to 3-independent 
experiments per timepoint with 3-5 mice per group analyzed with t-tests. *Analysis of MMMs on day 10 




























Figure 13.  Analysis of Eosinophils and CD11chi Dendritic Cell populations over the course of P. 
yoelii infection.  C57BL/6N mice were infected with 105 Py pRBCs. Spleens were collected from control 
or Py-infected mice on the indicated days post infection. A, C) Total numbers of cells per spleen on the 
indicated days. Myeloid cell populations were defined as follows: Eosinophils (CD3-, CD19-, F4/80-, 
SIGLEC+, CD11b+), CD11chi Dendritic Cells (CD3-, CD19-, F4/80-, SIGLEC-, Ly-6G-, CD11b+, CD11chi).  
B, D) Percent of splenocytes that are the indicated myeloid cell populations . Data (meanS.E.) are 




Effect of Plasmodium yoelii Infection of Anti-bacterial Functions of Innate Immune Cells 
Data obtained from the myeloid cell analysis did not show changes that correlated 
with our observation that Py+Lm coinfected mice have impaired Lm clearance up to 100 
days post Py-infection (Fig. 4), suggesting that antimicrobial functions of innate immune 
cells may be compromised by Plasmodium infection. To determine if impaired ROS 
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production is a mechanism by which Py suppresses innate immunity during bacteremia, 
spleens were removed from naïve control and Py-infected mice.  ROS production was 
quantified in whole spleen single cell suspensions in untreated cells or cells stimulated 
with PMA, unopsonized Lm, Lm opsonized with serum from naïve mice (N-Ops Lm), or 
Lm opsonized with serum from Py-infected mice (Py-Ops Lm). In general ROS 
production was much more pronounced in Ly-6G+CD11b+ PMNs than Ly-6G-CD11b+ 
“macrophages” (Fig. 14A). Consistent with increased Lm burden in Py-infected mice, 
PMNs from Py-infected mice showed decreases in intracellular ROS production (DCF 
geometric mean fluorescence intensity signal) in each of the stimulated groups (Fig. 14B-
C). In contrast, there was no difference in ROS production in Ly-6G-CD11b+ cells from 
Py-infected and naïve mice (Fig. 14D). Similar results were also observed when 
splenocytes were stimulated with heat-treated (Ht) Sp, Ht N-ops Sp, or Ht Py-ops Sp 
(Fig. 15).   
Additional analysis of the data suggests that Py infection may impede immunity to 
Sp, at least in part, through a serum-dependent effect. As seen in Figure 15C, Ht Sp 
opsonized with serum from naive mice (Ht N-ops Sp) compared to Ht Sp opsonized with 
serum from Py-infected mice (Ht Py-ops Sp) elicited increased ROS production in PMNs 
from naïve mice (naïve cells treated with Ht N-Ops Sp vs. naïve cells treated with Ht Py-
Ops Sp; open circle comparison in last two groups; unpaired t-test, p=0.00087). An even 
more pronounced serum-dependent effect was observed in PMNs from Py-infected mice 
(Py cells Ht N-Ops Sp vs. Py cells Ht Py-Ops Sp; gray-filled circle comparison in last 
two groups; unpaired t-test, p=0.00042). Of note, this serum-dependent effect was not 
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observed following stimulation of Lm (Fig. 14C). Collectively, these results identify 
impairment of ROS production in neutrophils as a potential mechanism by which Py  
suppresses antibacterial innate immunity during systemic bacterial infections, with an 




Figure 14. Splenic PMNs from P. yoelii infected mice have defective ROS production in response to 
Lm. C57BL/6N mice were infected with 105 Py pRBCs. Single cell suspensions from whole spleens of 
naïve and Py-infected mice (days 14 or 15 p.i.) were incubated with DFC to detect intracellular ROS. Cells 
were then treated with PMA, Lm, or Lm opsonized with 10% serum from naïve or Py-infected mice. A) 
Heat map displays DCF fluorescence in CD11b x Ly6G cells to indicate amount of intracellular ROS. Heat 
maps are from an individual mouse in each group that are representative of a single experiment and of three 
total independent experiments.  B) Histogram showing DCF fluorescence of splenic PMNs 
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(CD11b+/Ly6G+) as shown in box in (A). DCF geometric mean fluorescence intensity in PMNs 
(CD11b+/Ly6G+) (C) and macrophages/monocytes (CD11b+/Ly6G-) (D) populations as indicated in (A). 
Each symbol represents an individual mouse. Data (meanS.D.) are representative of three total 








Figure 15. Splenic PMNs from P. yoelii infected mice have defective ROS production in response to 
heat-killed Sp. C57BL/6N mice were infected with 105 Py pRBCs. Single cell suspensions from whole 
spleens of naïve and Py-infected mice (days 14 or 15 p.i.) were incubated with DFC to detect intracellular 
ROS. Cells were then treated with PMA, heat treated Sp (Ht Sp), or Ht Sp opsonized with 10% serum from 
naïve or Py-infected mice. A) Heat map displays DCF fluorescence in CD11b x Ly6G cells to indicate 
amount of intracellular ROS. Heat maps are from an individual mouse in each group that are representative 
of a single experiment and of three total independent experiments.  B) Histogram showing DCF 
fluorescence of splenic PMNs (CD11b+/Ly6G+) as shown in box in (A). DCF geometric mean fluorescence 
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intensity in PMNs (CD11b+/Ly6G+) (C) and macrophages/monocytes (CD11b+/Ly6G-) (D) populations as 
indicated in (A). Each symbol represents an individual mouse. Data (meanS.D.) are representative of three 
total independent experiments with 3 mice per group. Statistical significance was determined with multiple 
unpaired t-tests (D). 
 
Plasmodium yoelii infection impairs intracellular bacterial killing capacity of splenic 
phagocytes 
 To test impaired antibacterial responses at the cellular level, enrichment of splenic 
phagocytes was necessary because of the low overall abundance of macrophage, 
monocyte, and neutrophil subsets in the spleen, especially from Py infected mice (~~less 
than 10% of total splenocytes during Py infection).  Single cell suspensions of 
splenocytes from naïve control and Py-infected mice were enriched via depletion of 
CD3+ and CD19+ cells using a magnetic column.   Figure 16A shows expression of 
CD11b and CD11c on all viable cells after column depletion.  In order to further enrich 
for phagocytes, CD11b+CD11c- cells were then sort purified as indicated by the gate in 
Figure 16B.  Analysis of CD11b+CD11c- splenocytes identified that about half were Ly-
6G+ cells (Naïve=43.9%±3.95; Py-infected day 10=52.28%±7.40), indicating mixed 
populations of PMNs and mononuclear cells. Sort purified CD11b+CD11c- cells were 
infected with Lm in a 5-hour gentamycin protection assay. Consistent with elevated 
bacterial burden in Py-infected mice, CD11b+CD11c- cells from Py-infected mice 









Figure 16. P. yoelii 
infection impairs anti-
bacterial functions of 
splenic phagocytes.  A-
C) After C57BL/6N 
mice were infected with 
105 Py pRBCs, splenic 
phagocytes were 
enriched from naïve or 
Py-infected mice day 9 
post Py. Magnetic 
columns were used to 
enrich for splenic 
phagocytes by negative 
selection of CD3+CD19+ 
cells. A) Contour plot 
showing CD11b and 
CD11c expression on 
viable splenocytes prior 
to T and B cell depletion 
on magnetic column. B) 
Contour plot showing 




depletion of T and B 
cells. Circle indicates the 
population of splenic 
phagocytes that was sort 
purified for gentamicin 
protection assays. 
CD11bhiCD11c- cells 
were then sort purified 
for experiments. C and 
D) 105 sort-purified 
CD11bhiCD11c- splenic 
phagocytes were plated 
in each well and infected 
with Lm opsonized with 
homologous mouse 
serum with MOI=100. 
Intracellular Lm burden 
was determined after 2 
hours and 5 hours (C) in 
a gentamicin protection 
assay to evaluate fold 
change at 5 hours post 
infection (D). Fold 
change in intracellular 








Due to the consistent outcome of elevated bacterial burdens in spleens of 
coinfected mice for both Lm and Sp models described in Chapter II, and the overall 
importance of this organ and the specific subsets of tissue-resident macrophages within 
during invasive bacterial infections, we sought to explore how populations of innate 
immune cells fluctuate over the course of P. yoelii infection. While other published work 
has shown decreases or even complete loss of some myeloid cell subsets in P. chabaudi 
or P. berghei murine malaria models, this Chapter aimed to characterize these changes in 
P. yoelii infection and describe difference between Py infected and naïve mice from day 
10 post infection to 2 months beyond clearance of the infection.  A major difference 
between the methods used in this work and previous work is that we used a flow 
cytometric analysis that allowed for quantitative measurement of surface marker 
expression on a single cell level, whereas other work was conducted on the somewhat 
qualitative method confocal microscopy.  An advantage of using our flow cytometric 
method is that it allows us to examine how the total numbers of each population changed 
over time and how the relative abundance of each cell subset changed with respect to the 
total numbers of cells in each spleen.  Also, compared to analysis of tissue sections via 
confocal microscopy, our method of cellular analysis by flow cytometry allows for 
quantitative measurement of a higher amount of cell surface markers, providing a more 
complete picture of splenic myeloid cell populations.   
Due to the exhaustive nature of our splenic myeloid cell population analysis, we 
found no existing study that examined a similar multitude of cell types in the context of 
Plasmodium infection or any other disease.  Therefore, many considerations were made 
in generating the panel of cell surface markers that were used to identify specific cell 
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populations, choosing proper combinations of conjugated fluorochromes, and conceiving 
an informed gating strategy.  In this manner, we took advantage of literature describing 
surface markers that are known to have specific levels of expression on cell population 
subsets of interest in order to improve the accuracy and power of our analysis.  
Characterizations of multiple cell populations within an organ or tissue are able to 
identify a specific cell type based on high expression or absence of a single surface 
marker that has been associated with an individual cell-type.  In this work, however, 
several cell subtypes examined share nearly identical expression of multiple identifying 
surface markers due to their common hematopoietic origin.  Since RPMs are known to be 
frustratingly autofluorescent [157, 158], they were the first cell type defined in our gating 
strategy immediately following the elimination of lymphocytes from the analysis, where 
CD3/CD19 positive cells separated (Fig. 11).  To improve this cell analysis scheme in the 
future, the intrinsic autofluorescence of RPMs could be utilized by including and 
recording an open fluorescence channel, such as FITC, APC, or PE-Cy7, each of which 
have previously been demonstrated to have clear peaks that identify unstained RPMs as 
distinct from unstained dendritic cells as shown in Franken et. al [157] in Supplementary 
Figure 1.  This method for identifying RPMs has also been demonstrated by Mitchell et. 
al 2012 [159].   
Our results indicate that significant changes in several of the cell types examined 
occur during Py parasitemia and remain for up two months after parasite clearance. 
Among the cell types that are known to be important in clearance of invasive bacteria in 
the bloodstream, only MZMs were decreased in spleens of Py infected mice 101-102 
days post Py infection.  Lower numbers of MZMs at this time point correlates with 
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impaired antibacterial innate immunity.  Yet, MZMs were elevated in Py infected mice 
compared to control mice day 10 post Py infection when mice also displayed impaired 
bacterial clearance.  Consequently, the initial increase and subsequent loss of MZMs in 
the spleen does not appear to change the bacterial clearance abilities in this model 
system.   
There is strong rationale to hypothesize that one or more of the phagocytic cell 
populations characterized in this work become unable to perform anti-microbial functions 
during and following Plasmodium infection.  While we were able to show defective 
control of intracellular replication in a more generally defined population of splenocytes 
from Py-infected mice that contained a mixture of macrophages, monocytes, and 
neutrophils (Figure 16), more work is needed to determine whether this defect is specific 
to a single cell type or if it is common to multiple.  Similar results were obtained when 
using sorted splenic phagocytes from Py-infected mice on both days 9-11 (Figure 16) and 
day ~30 (data not shown) post infection in the ex vivo gentamicin killing assay, 
suggesting that there could be a common mechanism during acute parasitemia and at a 
time point shortly after parasite clearance.  Chapter IV will seek to test the hypothesis 
that exposure to hemozoin is sufficient to impair control of intracellular Lm replication.  
 Another limitation of the in vitro gentamicin protection assay is the inability to 
determine whether a particular cell type has defective functions or if there is a general 
defect in multiple splenic phagocyte populations. Given that both  Plasmodium chabaudi 
and Leishmania donovani infections induce loss of MZMs and MMMs, and Sp sepsis 
increases involvement of RPMs in their absence following L. donovani infection, there is 
rationale to specifically test the ability of RPMs to eliminate Sp, and compare this to 
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purified cultures of MZMs, MMMs, and mixed cultures [133, 134].  This type of 
experiment would potentially show stronger phenotypes if there are cells with normal 
functional ability diluting and diminishing the effect.  Knowledge of functional capacity 
of specific cell types to control bacteria in vitro would provide meaningful insight into 
the potential mechanisms of the enhanced mortality we’ve observed in our Py+Sp 
coinfection model. There are, however, other factors that may contribute to the impaired 
clearance of Lm at early and late time points post infection, respectively.  For example, 
loss of functional complement components during the parasite infection could decrease 
bactericidal capacity of the innate immune cells despite the initial increase in MZMs that 
would otherwise aid in bacterial clearance under normal conditions.  Additionally, at time 
points that follow clearance of Py, complement factor function returns to normal (only 
observed in P. berghei/chabaudi), yet at this time the loss of total numbers of MZMs may 
be responsible for the long-term impaired clearance of Lm.  Further experiments are 
needed in order to completely understand exactly which anti-bacterial mechanisms of 
which specific cell types are impaired at different timepoints in this model system.   
Additionally, our analysis is not able to detect changes in the ability of migratory 
innate immune cell populations to infiltrate the spleen in response to a secondary 
bacterial infection.  There is strong evidence suggesting that monocyte, neutrophil, and 
dendritic cells have impaired chemotaxis [117, 160], antigen presentation, and other 
antimicrobial functions in the context of Plasmodium infections [61, 161-164].  It is 
likely that the during/after Plasmodium infection the inability of these cells to 
migrate/egress from circulation into the spleen impedes the clearance and overall 
immunity to bacterial coinfections 
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Prior studies characterizing changes in populations of splenic myeloid cells during 
disease have utilized confocal microscopy of spleen sections, which allows for 
characterization of splenic architecture and the position of cells relative to landmarks 
such as red pulp, white pulp, marginal zones, and germinal centers [134].  While this 
approach is useful for evaluating the stage of maturation or extent of adaptive immune 
responses, it is only partly quantitative and therefore does not provide a full picture of 
spleen functions.  Splenomegaly and disruption of marginal zone architecture during 
malaria makes analysis of cell types based on location in tissue problematic due to a lack 
of important landmarks.  We chose to use a flow cytometry method for analysis of 
splenic innate immune cell populations because it allowed us to take advantage of 
differential expression of surface markers to identify specific subsets, such as MMMs and 
MZMs, without limiting the number of cell types we could explore in a single sample.   
 The gating strategy and definitions of cell populations was developed by 
combining strategies from previous studies – for neutrophils, eosinophils, dendritic cells, 
inflammatory monocytes, and red pulp macrophages [165].  Since no other study had 
previously characterized MMMs and MZMs with flow cytometry, a method for detecting 
these cells was devised by drawing gates based on the fluorescence-minus-one(FMO) 
samples, which were stained with all antibodies other than the one being examined.  
Discrepancies in background autofluorescence of PE and APC (recognizing CD169 and 
CD209b and identifying MMMs and MZMs, respectively) were evident between samples 
from naïve and Py-infected mice at all timepoints post Py infection and gates were drawn 
accordingly for all samples in respective naïve or Py infected mouse groups 
independently for each experiment/repeat.  In each experiment cells from Py-infected 
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mice appeared to have higher background autofluorescence in APC and PE channels than 
cells from naïve mice despite the trend of these markers being expressed more highly in 
cells from naïve mice (data not shown).  Whether or not this observation was occurring in 
other cell types/fluorophore channels was not assessed, and further analysis should be 
done to determine the overall impact it may have had on these results. One explanation 
for this observation that convoluted the analysis is that some factor related to the Py 
infection increased the overall autofluorescence of MMMs, MZMs, and possibly other 
cell populations, which would potentially impact absolute and relative numbers of every 
cell type that was examined.   
The activity of Plasmodium-induction of serine proteases presents another 
potential explanation of both the observed loss of splenocyte subpopulations during some 
but not all timepoints analyzed post-Py infection, and the technical problem of 
inconsistent baseline (unstained) levels of MMM and MZM markers.  During the blood 
stage of Plasmodium infection both parasite and host immune cells produce factors, such 
as Plasmodium serine proteases and neutrophil elastase (also a serine protease), that are 
capable of cleaving surface molecules from innate immune cells, including toll-like 
receptors, and intracellular adhesion molecule-1(ICAM-1/MAC1/CD54) [166, 167].  
This receptor-cleaving activity may be occurring during Py infection and cleaving 
immune cell surface proteins that are not yet known to be affected.  In this scenario, the 
impact of proteases on immune cell surface markers may vary over the course of 
infection with cleavage decreasing as the course of the infection nears senescence and 
eventually having no affect. Hypothetically, this situation would have an immense impact 
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on our analysis and accounting for this phenomenon would be essential for accurate 
comparisons between naïve and Py-infected mouse splenocyte populations.   
Previous work from both clinical studies and animal models describe impaired 
ROS production by PMNs isolated from Plasmodium-infected individuals and mice [61, 
62, 64].  These reports linked the lack of sufficient respiratory burst observed during 
acute severe malaria cases as well as months after senescence to the clinical observations 
that demonstrated an elevated susceptibility to invasive NTS coinfections [53, 56, 168, 
169].  The experiments performed in these investigations measured ROS production from 
neutrophils isolated peripheral blood or bone marrow following stimulation with PMA, in 
one case, 1x108 cfu of opsonized S. typhimurium in vitro [64].  To date, defective 
neutrophil functions, including impaired ROS production, chemotaxis, and general 
impairment of bacterial killing – is attributed to the activity of HO-1 related to 
Plasmodium infection induction of hemolysis [61, 62, 64].  While the impaired ability of 
PMNs to produce sufficient level of ROS needed to kill intracellular NTS was clearly 
demonstrated, these studies raise several questions. Both Cunnington et al. [61] and 
Nyirenda et al. [64] detected decreased ROS production in PMNs from patient samples 
obtained either 4 to 8 weeks after the initial check and treatment with artemether-
lumefantrine or other anti-malarial drugs.  
In this work we sought to examine ROS production in myeloid cells from spleens 
from Py infected mice compared to naïve mice.  Since parasite-dependent hemolysis 
occurs only during active replication of the parasite in the erythrocytic stage of infection, 
and we had found impaired clearance of Lm and increased susceptibility to Sp during Py 
coinfection (Figures 4 and 8 in Chapter II), we hypothesized that factors other than HO-1 
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and hemolysis may be contributing to the Plasmodium-dependent defect in PMN ROS 
production.  Additionally, we sought to characterize ROS production in myeloid cells 
from the spleen, an organ of great importance during invasive bacterial infections [39, 
124, 156], rather than from peripheral blood.  Also, we hoped to determine whether the 
impaired ROS production occurred in macrophages and monocytes within the spleen, or 
if this defect was specific to PMNs.  Finally, our ex vivo assay was designed to test 
intracellular ROS production of splenocytes in response to Lm and Sp, with the addition 
of PMA stimulation to serve as a positive control.   
We found that Py infection significantly impaired ROS production by PMNs, but 
not “macrophages” (CD11b-, Ly-6G-), when treated with PMA, Lm, and heat-treated Sp.  
It is known that PMN production of ROS is sufficient to kill intracellular Lm [154], and 
therefore, this result supports our hypothesis that Py-infection induced reduction in PMN 
ability to produce ROS contributes to the impaired clearance of Lm in spleens of 
coinfected mice. We also observed reduced ROS production of splenic PMNs from Py-
infected mice in response to heat-treated Sp.  This defect likely does not affect killing or 
clearance of Sp since it is know that Pneumococcus can survive significant levels of 
oxygen radicals and in fact produces hydrogen peroxide (H2O2), which acts together with 
pneumolysin toxin to kill host cells independent of caspases [170], and disrupts alveolar 
epithelium as a mechanism to initiate firm adherence while invading the respiratory tract 
[171].  It is possible, however, that the decreased ROS production in splenic PMNs from 
Py-infected mice is a symptom of a larger defect in anti-microbial functions.  This idea 
will be explored further in Chapters IV and V. 
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Py infection may also impair the innate immune response to invasive bacteria via 
serum-dependent effects. Complement components C1q and C3 interact with parasitized 
RBCs during P. falciparum infection, initiating the complement cascade, which leads to 
reduced serum levels of C1q and lower complement activity compared to uninfected 
individuals [120, 155]. Several components of the complement system are considered 
essential for immunity to Sp infection, as individuals with genetic defects in C3, which is 
involved in both the classical and alternative complement pathways, experience recurring 
pneumococcal infections and infections with other encapsulated bacteria. Similarly, mice 
lacking expression of C3, factor B, C1qa, or C4 genes are more susceptible to Sp 
infections [153]. Moreover, killing of Sp by neutrophils has been shown to require active 
complement opsonophagocytosis via CR3 (CD11b/CD18 heterodimer complement 
receptor) [172]. Consistent with Plasmodium-induced depletion of complement and a role 
for complement in immunity to Sp, we observed decreased ROS production in splenic 
PMNs from naïve mice stimulated with heat-killed Sp opsonized with serum from Py-
infected mice compared to splenic PMNs stimulated with heat-killed Sp opsonized with 
serum from naïve mice (Fig. 15A-C). Similarly, PMNs from Py-infected mice showed 
increased ROS production following stimulation with heat-killed Sp opsonized with 
serum from naïve mice compared to serum from Py-infected mice. This observation 
could indicate a serum factor-dependent defect in neutrophil opsonophagocytosis that 
may lead to impaired immunity to Sp during malaria. Although ROS bursts within 
neutrophil phagolysosomes are not sufficient to kill Sp [172], deficiency in PMN ROS 
production in response to heat-killed Sp opsonized with serum from Py-infected mice 
compared to heat-killed Sp opsonized with serum from naïve mice suggests that 
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phagolysosome maturation, or other events that follow opsonophagocytosis, may be 
inhibited or less responsive. It has also been shown that serum from febrile P. falciparum 
infected individuals results in decreased C3 deposition on NTS compared to serum from 
non-febrile P. falciparum negative individuals [63]. Collectively, these observations 
suggest that complement depletion during Plasmodium infections may be a general 
deficiency associated with invasive bacterial infections.  
 To better understand the interaction between phagocytic cells of the spleen and 
Lm in the context of malaria, the gentamicin protection assay was developed. This 
technique allowed us to compare intracellular bacterial burdens in cells from spleens of 
Py-infected and naïve at various times post-infection to determine whether Plasmodium 
infection effected the cell’s ability to control intracellular replication (Fig. 16).  At the 
early timepoint of 2 hours post Lm infection, fewer CFUs were detected in cells from Py 
infected mice.  This result can be interpreted in several ways.  First, a difference in Lm 
adherence could alter either uptake of Lm by phagocytosis or Lm invasion of cells in this 
assay.  Since gentamicin was added to the culture 1 hour after infection, attached Lm and 
other extracellular Lm are killed and differences in Lm attachment to the surface of cells 
from naïve and Py-infected at this time would no longer impact the resulting bacterial 
burdens 1 or 4 hours later when bacteria was plated for cfu analysis.  It may be that 
splenic phagocytes from Py-infected mice have some modified surface components that 
impede Lm attachment, and subsequent invasion or uptake.  Alternatively, changes in 
serum factors during Py infection, such as opsonins: antibody and complement factors, 
could change dynamics of Lm ability to induce its uptake.  Some other factors that could 
influence numbers of intracellular bacterial burdens after 2 hours are differences in 
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extracellular and intracellular killing.  Neutrophils encountering Lm in these in vitro 
conditions would be capable of producing bactericidal granules and NETs.  They would 
also have adequate time to internalize Lm and fuse Lm-containing phagosomes with 
granules and combining anti-microbial components such as proteases and ROS. 
Therefore, lower CFUs in cells from Py-infected mice may have resulted in increased 
ability of these cells to kill extracellular Lm, intracellular Lm, or both.  Finally, the 
decreased bacterial burdens seen in cells from Py-infected mice could be explained by a 
general defect in Lm phagocytosis, which has been previously described in the context of 
malaria and hemozoin [85, 173, 174].   
 While results at 2 hours post Lm infection indicated lower intracellular Lm 
burdens in cells from Py-infected mice,  CFU analysis at 5 hours post-Lm infection  
showed a drastic increase compared to almost no change in cells from naïve mice       
(Fig. 16 C).  This result indicates that cells from Py-infected mice, despite having lower 
Lm burdens at 2 hours post infection, were permissive to Lm growth between 2 and 5 
hours, whereas cells from naïve mice were capable of controlling Lm intracellular 
replication (Fig. 16 C and D).  This result introduces several important questions 
pertaining to the Py-dependent mechanism(s) that are rendering splenic phagocytes into 
permissive to bacterial growth.  Previous reports that investigated Plasmodium 
coinfections with NTS have found that Py hemolysis-induced HO-1 and IL-10 inhibit 
essential functions of innate immune cells and are sufficient to increase the overall 
severity of NTS infection [59, 61, 62, 64].  In the case of immunity to Lm in our Py+Lm 
coinfection model, however, it is unlikely HO-1 or IL-10 are contributing to the defective 
control of Lm growth as we found that inhibiting either of these factors did not improve 
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Lm clearance in coinfected mice (Fig. 6). Lm is susceptible to intracellular production of 
ROS within phagocytic cells, specifically neutrophils [175].  We found that PMNs from 
Py-infected mice have defective ROS production in response to Lm (Fig. 14).  Additional 
experiments are required to determine whether defective ROS production is contributing 
to this phenotype and if the defect is specific to a particular cell type (monocyte, 
macrophage, and/or neutrophils), as the cells sorted for this assay contained a mixture of 
all CD3/CD19-/-, CD11c- and CD11b+, which should only eliminate all lymphocytes, and 































THE PARASITE FACTOR HEMOZOIN IMPAIRS INNATE IMMUNITY TO 





During the blood stage of Plasmodium infection, parasites within infected 
erythrocytes release proteases to digest protein components of hemoglobin within their 
digestive vacuoles resulting in the release of free heme, which is toxic to the parasite. 
Heme is detoxified within the parasite digestive vacuole via non-enzymatic 
polymerization into hemozoin (Hz), which is an insoluble crystal structure[176]. 
Following erythrocyte rupture and merozoite escape, Hz is released into circulation and 
engulfed by phagocytic cells resulting in deposition in tissues and organs such as spleen, 
liver, brain, lungs, and bone marrow. Hz deposition following Plasmodium berghei 
infection was evident in the spleen, liver, bone marrow, and peripheral blood 196 days 
after infection [110]. Hz has also been reported in lung and brain tissue of P. berghei and 
Plasmodium chabaudi infected mice [83] and is involved in the malaria-driven 
pathologies specific to those organs, such as malaria-associated acute respiratory distress 
syndrome and cerebral malaria, respectively [81, 177, 178] . 
 The immune modulatory potential of Hz has been examined in several studies 
with a wide variety of Hz preparations and cell types being used.  While synthetically 
generated Hz has been described in some cases as “immunologically inert”, others have 
86 
 
found Hz formed naturally during erythrocyte infection to alter and impair many immune 
cell functions [179].  For example, uptake of parasitized RBCs or purified Hz by human 
monocyte-derived macrophages causes impaired phagocytosis of additional RBCs or 
production of a PMA-induced oxidative burst [173], which are impaired via Hz-
dependent inactivation of protein kinase C and NADPH-oxidase [164, 180]. Purified 
digestive vacuoles with intact membranes (not sonicated or detergent treated) isolated 
from P. falciparum-infected RBC culture have been shown to activate complement, and 
decrease ROS production and bactericidal capacity of human PMNs [161, 162].  
Internalization of Hz has also been found to induce the production of pro-inflammatory 
cytokines such as IL-1β and TNF and also increase chemokine production and enhance 
expression of their receptors (CCL3-5, MCP-1) in mouse macrophages and human 
peripheral blood monocytes [181, 182]. Antigen presentation functions and overall 
functional maturation of dendritic cells are also impacted, as decreased surface 
expression of CD54, CD11c, and MHC-class II in human PBMCs following stimulation 
with IFN-γ has also been observed during co-incubation with Hz [163]. 
Few studies, however, have looked directly at the interactions between innate 
immune cells and Hz in the context of in vivo bacterial infection or the effect of Hz on 
neutrophil function, and we have found none to date that have explored interactions with 
Streptococcus pneumoniae infection.  Moreover, previous work has shown impaired 
antimicrobial functions of innate immune cells from African children with uncomplicated 
malaria that lasted up to 8 weeks after antimalarial treatment [61]. Of note, there is 
unlikely to be parasite-induced hemolysis during convalescence, which is the current 
hypothesis by which Plasmodium suppresses anti-bacterial innate immunity. Collectively, 
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this leads to the hypothesis that Hz contributes to Plasmodium-induced suppression of 
innate immunity to bacterial infections.   
The aim of this Chapter is to explore the immunomodulatory properties of Hz in 
the context of bacterial infections and the innate immune cell functions that are vital to 
controlling invasive bacterial infection.  To test these hypotheses, a novel method of 
isolating and purifying hemozoin from livers and spleens of Py-infected mice (PyHz) was 
developed.  The addition of PyHz to cultures of innate immune cells in vitro and injecting 
intravenously into naïve mice prior to bacterial infection allowed us to gain insight into 
the interaction between this parasite metabolic byproduct and how bioactive molecules 
associated with Hz contribute to Plasmodium-induced immunosuppression. 
 
Results 
Impact of Plasmodium-derived hemozoin on anti-bacterial functions and control of 
intracellular bacterial replication in splenic phagocytes 
 
 Hemozoin has been shown to remain in host tissues, including the spleen, for many 
months after the clearance of infection [83, 110]. This physical characteristic of Hz and 
the long-term suppression of innate immunity to bacteremia following clearance of 
Plasmodium yoelii (Fig. 4C), led to the hypothesis that Hz is a parasite-derived factor that 
is capable of impairing anti-bacterial effector functions.  To perform these studies, we 
developed an approach to isolate Hz from the spleens and livers of mice that had cleared 
Py infections (Figure 17).  An image of Hz formed in food vacuole of P. falciparum is 
shown in Figure 17A [183].  After collecting the organs (spleens of naïve and Py-infected 
mice shown in picture Figure 17B) they were thoroughly homogenized and then washed 
in de-ionized water and then passed through a 100-micron nylon mesh filter to remove 
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remaining pieces of tissue.  Next hemozoin was suspended in PBS before being added to 
the top of a discontinuous Percoll density gradient with 40% and 80% fractions (Fig. 17 
C).  Hemozoin was collected from the interface between the 40 and 80% fractions as well 
as beneath the 80% fraction.  Isolated hemozoin from Py-infected mouse organs (PyHz) 
was finally washed in 2mM mannitol-containing buffer and resuspended in sterile saline 
prior to use.  Details of other Hz preparations can be found in the Materials and Methods 
section. 
Figure 17. Hemozoin isolation from 
liver and spleens of Py-infected mice. A) 
Hemozoin crystals within the digestive 
vacuole of P. falciparum, color was added 
with imaging software (adapted from D. 
Jani et al. 2008 [183].  B) Spleens from 
naïve, 14, and 28 day Py-infected mice.  
Dark color in Py-infected spleens due to 
Hz deposition.  Adapted from C) Percoll 
gradient used for isolation of hemozoin 
collected from homogenized spleens and 














 To test the hypothesis that Hz contributes to Py-induced immune suppression, we 
first examined whether Hz contributed to the defective production of ROS that was 
observed in splenic PMNs isolated from Py-infected mice (Fig. 14 and 15).  Single cell 
suspensions from whole spleens isolated from naïve mice were incubated with PyHz for 
6 or 16 hours prior to stimulation with Lm, Sp, or control PMA (Fig. 18).  One hour after 
stimulation with bacteria or PMA, cells were treated with DCF and intracellular ROS was 
measured via flow cytometry.  Low levels of ROS were detected in both untreated cells 
and cells treated with PyHz alone (Fig. 18A,C-D).  While PMA stimulation induced 
similar ROS in untreated and PyHz treated PMNs, opsonized Lm and heat-treated 
opsonized Sp did not elicit a robust ROS response (Fig. 18A-D).  In contrast, both 
untreated and PyHz-treated PMNs infected with live-opsonized Sp had high levels of 
ROS (Fig. 18A-D), with PyHz-treated PMNs exhibiting significantly higher ROS than 
untreated samples (Fig 18D).  Similar results were observed in the spleen CD11b+/Ly-





Figure 18. PyHz treatment does not alter intracellular 
ROS production of splenic neutrophils in whole spleen 
single cell suspension. Single cell suspensions from whole 
spleens of naïve mice were incubated with 60μg hemozoin 
isolated from liver and spleen homogenate from Py-infected 
mice(PyHz) for 6 or 16 hours.  After incubation with PyHz, 
cells were incubated with DFC to detect intracellular ROS. 
Cells were then treated with PMA, opsonized ΔactA Lm 
(Ops-Lm), heat treated opsonized Sp (Ht Ops-Sp), or 
opsonized live Sp (Ops-Sp). A and B) Heat map displays 
DCF fluorescence in CD11b x Ly6G cells to indicate amount 
of intracellular ROS. A) and B) display the same data for the 
Ht Ops-Sp group, B) includes the live Ops-Sp group with an 
increased maximum DCF signal for improved visualization of changes in ROS production.  Heat maps are 
from an individual mouse in each group that are representative of a single experiment and of three total 
independent experiments.  C) Histogram showing DCF fluorescence of splenic PMNs (CD11b+/Ly6G+) as 
shown in box in (A). DCF geometric mean fluorescence intensity in PMNs (CD11b+/Ly6G+) (D) and 
macrophages/monocytes (CD11b+/Ly6G-) (E) populations as indicated in (A and B). Each symbol 
represents an individual mouse.  F) DCF geometric mean fluorescence of untreated and PyHz-treated 
PMNs (CD11b+/Ly6G+) as shown in box in (A) incubated in the indicated conditions for 6 and 16 hours 
prior to DCF treatment and PMA stimulations or infections. Data (meanS.D.) are representative of three 
total independent experiments with 3 mice per group for (D - F). Statistical significance was determined 





 Since we did not observe differences in ROS production between PyHz treated and 
untreated PMNs, or other cell populations from whole spleen single cell suspensions, a 
purified population of neutrophils were isolated from bone marrow of naïve mice and 
incubated with PyHz prior to infection with Lm and Sp in order to increase the amount of 
interaction between our cells of interest and the Hz.  The purity of neutrophils in the 
population was determined based on the Ly-6G+/CD11b+ gate drawn in Figure 19 A and 
compared to total single cells (Fig. 19C).  These conditions were also performed with 
hemozoin isolated from red blood cell cultures of the important human pathogen, P. 
falciparum (PfHz).  Following incubation with Hz, cells were treated with DCF and then 
stimulated with PMA or with opsonized Lm, Ht Ops Sp, or live Ops-Sp.  Similar to what 
was observed using whole spleen single cell suspensions, incubation with PyHz or PfHz 
did not impair intracellular ROS production in bone marrow purified neutrophils (BMNs) 
(Fig. 19).  Increased ROS in cells stimulated with live opsonized Sp was seen again in 
this experiment, comparable to the result in Figure 18 with whole spleen single cell 
suspension and Hz treatment. Purified BMNs with PyHz or PfHz treatment contained 
high levels of ROS when stimulated with live opsonized Sp (though not as high as in 
PMNs in whole spleen single cell suspension), yet BMNs that were not treated with PyHz 
or PfHz displayed similar DCF signal as unstimulated cells following infection with live 
opsonized Sp (Fig. 19D). Together, these data indicate that the ability of BMNs as well as 








Figure 19. Hemozoin treated bone-marrow-purified 
Neutrophils do not have defective ROS responses. 
Purified bone marrow neutrophils (BMNs) were isolated 
from naïve mice and incubated with 60μg of either hemozoin 
isolated from liver and spleen homogenate from Py-infected 
mice(PyHz) or hemozoin isolated from Plasmodium 
falciparum-infected human red blood cell culture (PfHz).  
After incubation with PyHz or PfHz for 4-5 hours, cells were 
incubated with DFC to detect intracellular ROS. Cells were 
then treated with PMA, opsonized ΔactA Lm (Ops-Lm), heat 
treated opsonized Sp (Ht Ops-Sp), or opsonized live Sp 
(Ops-Sp). A) Heat map displays DCF fluorescence in 
CD11b+ x Ly6G+ cells to indicate amount of intracellular 
ROS. Each heat map layout is from an individual mouse in each group that are representing one of three 
independent experiments. B) Histogram showing DCF fluorescence of purified BMNs (CD11b+/Ly6G+) as 
shown in the gate in (A). DCF geometric mean fluorescence intensity in BMNs (CD11b+/Ly6G+) (C). 
Percent purity of BMNs in each sample determined as percent of CD11b+/Ly6G+ single cells (D). Each 
symbol represents an individual mouse.  ed in box in (A) incubated in the indicated conditions for 6 and 16 
hours prior to DCF treatment and PMA stimulations or infections. Data (meanS.D.) are representative of 
three total independent experiments with 3 mice per group for (C and D). Statistical significance was 




In order to assess the ability of parasite derived hemozoin to contribute to 
impaired innate immunity to bacterial coinfections, we sought to create a coinfection 
model that utilizes a Plasmodium parasite that is deficient in Hz production. Mutant 
strains of P. berghei (Pb) NK65 were obtained to determine whether the absence or a 
significant decrease of Hz production during Plasmodium infection would improve 
clearance of Lm compared to wild-type Pb NK65. We acquired Δpm4, a Pb NK65 mutant 
strain that lacks plasmepsin 4 (pm4), a gene encoding a protease involved in digesting 
hemoglobin [184]. Given the importance of Hz formation in the detoxification of heme 
within infected RBCs, Pb strains with impaired Hz production have an attenuated 
phenotype characterized by a significantly reduced parasitemia during infection [184].  
To ensure that decreases in parasitemia were not responsible for any phenotypes 
observed, we also obtained a Pb strain lacking a gene encoding dipeptidyl 
aminopeptidase 2 (Δdpap) that exhibits attenuated parasitemia similar to Δpm4.  These 
strains were kindly provided by Dr. Phillipe Van den Steen from KU Leuven–University 
of Leuven, in Leuven, Belgium.  Mice were given intraperitoneal injections with 104 
pRBCs of the wild type Plasmodium berghei strain NK65 (Pb wt), Pb Δdpap, and Δpm4 
obtained from infected donor mice and parasitemia was measured on days 6, 8, and 9.  
On day 7 post Pb infection, injections of 5x106 CFU of ΔactA Lm were administered to 
Pb-infected mice and naïve controls.  As expected, mice infected with Pb Δdpap, and 
Δpm4 strains had lower parasitemia than wild type (Fig. 20A). While Δpm4 infected mice 
had significantly less Hz than WT in both liver and spleens by day 9 post Pb infection, 
Hz levels in Δdpap infected mice trended lower in spleens compared mice infected with 
WT Pb NK65, and was significantly less than levels found in livers of WT infected mice 
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(Fig. 20B and C).  On day 9 post Pb NK65 infection (day 2 post Lm), spleens and livers 
were removed, and bacterial burdens were analyzed.  Similar to what was observed in 
Py+Lm, mice coinfected with Pb and Lm had higher bacterial burdens in spleens and 
livers than mice infected with Lm alone. However, contrary to our hypothesis, Lm 
burdens in Δpm4-infected mice were higher than Pb wt-infected mice in spleens and 
trended higher than Δdpap-infected mice (Fig. 20D and E).  Based on the data gathered 
from these experiments, deficiency in Hz production in this coinfection model do not 
impair clearance of Lm and more work is required to produce a model system where a 
normal Plasmodium infection can occur with the absence of Hz deposition in tissues and 

















Figure 20. Infection with 
Plasmodium berghei mutant 
deficient in Hz does not 
delay ΔactA  Lm clearance.  
C57BL/6 mice were given an 
intraperitoneal injection of 
1x104 pRBCs collected from 
donor mice infected with 
strains Pb NK65 (wt), Pb 
NK65 DPAP-  (DPAP-), or Pb 
NK65 PM4- (Pm4-).  
Parasitemia was analyzed on 
days 6, 8, and 9 post infection 
via flow cytometry (A). On 
day 7, naïve control mice and 
groups of 5 mice were 
infected with each of the three 
Pb mutant strains were 
infected with 5x106 CFU of 
ΔactA Lm.  On day 9 post Pb 
infection (day 2 post Lm), 
mice were sacrificed, and 
spleen and liver tissues were 
collected for both Hz 
quantification (B and C) and 
bacterial burdens (D and E).  
Data (mean ± S.D.) are 
representative of a total of 
three independent 
experiments.  Statistical 
significance was determined 
by one-way ANOVA 






Although we did not observe defective ROS production in innate immune cells 
treated with Hz in vitro or improved Lm clearance in spleens of mice infected with Hz-
deficient Plasmodium, our strong rationale to investigate the immunosuppressive activity 
of Hz led us to investigate the effect Hz has on survival of bacteria within splenic 
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phagocytes.  Therefore, we used a gentamicin protection assay using sort-purified splenic 
phagocytes to test the hypothesis that in presence of Hz, cells would have a defective 
ability to or control the intracellular growth of Lm.  PyHz extracted from spleens and 
livers of mice that had cleared a Py infection was incubated with sort purified splenic 
phagocytes from naïve mice for 1-2 hours before cells were infected with Lm in a 
gentamycin protection assay, as described in Figure 13 in Chapter II.  Following 
incubation with PyHz, some CD11b+CD11c- cells had phagocytosed PyHz, while others 
did not (Fig. 21A). Consistent with the hypothesis, PyHz impaired the ability of 
CD11b+CD11c- to kill intracellular Lm compared to PBS treated cells (Fig. 21B and C). 
These data demonstrate that a parasite-derived factor (PyHz) was capable of impairing 



















Figure 21. P. yoelii -derived hemozoin 
and bound bioactive molecules impair 
anti-bacterial functions of splenic 
phagocytes. 105 sort-purified 
CD11bhiCD11c- splenic phagocytes 
were enriched, as in Figure 13 (A-B), 
from naïve mice and were incubated 
with 30μg hemozoin purified from 
spleen and livers of mice previously 
infected with Py (PyHz) for 1-2 hours. 
A) A giemsa-stained cell containing 
internalized PyHz (brown pigment), 
indicated by arrow, and PyHz negative 
cells containing no visible uptaken 
pigment. Intracellular ΔactA Lm burden 
was determined after 2 hours and 5 hours 
(B) in a gentamicin protection assay to 
evaluate fold change at 5 hours post 
infection (C).  Fold change in intracellular 
bacteria was determined by cfu/well at 5 
hours post infection divided by cfu/well at 
2 hours post infection. Data (meanS.D.) 
are representative of 3 independent 
experiments each symbol represents an 
individual replicate of pooled cells from 3 
mouse spleens per group. Statistical 





In vivo analysis of Hz-induced suppression of innate immunity during bacterial infection 
To test whether PyHz was able to impair the clearance of Lm in vivo, naïve mice 
were given intravenous injections of PyHz followed by ΔactA Lm infection 7-days later. 
PyHz was observed in some, but not all circulating leukocytes both 1- and 7-days post 
injection as well as in spleen and liver cells 9-days after injection (Fig. 22A). PyHz could 
also be quantified in both the spleen and liver 9-days post PyHz injection (Fig. 22B). 
When Lm burden was quantified, PyHz treated mice had an elevated burden in the spleen 
(Fig 22C).  With this data, we have shown that a parasite factor alone, PyHz, is capable 





Figure 22. P. yoelii hemozoin with bound bioactive molecules is sufficient to impair clearance of 
ΔactA Lm in vivo. C57BL/6N mice treated i.v. with 1mg PyHz isolated from livers and spleens of Py 
infected mice (A-C). 7 days after Hz treatment mice were infected with 5x106 CFUs ΔactA Lm.  A ) 
Giemsa stained peripheral blood smears and cells mounted from spleen and liver single cell suspensions on 
the indicated days post Hz treatment. Arrows indicate the presence of intracellular Hz, visible as brown 
pigment. PyHz and PfHz-negative leukocytes were present at indicated time points in peripheral blood, 
spleen or liver with no visible intracellular Hz pigment (B and E) Quantification of Hz in spleens and 
livers. Data (meanS.D.) are from a single experiment representing three independent experiments. Dotted 
lines represent the limit of Hz detection. Bacterial burden in spleens of PyHz (C) PfHz (F) or untreated 
control mice was determined 2 days post Lm infection. Data (meanS.E.) are cumulative results from 2-3 
independent experiments. Each symbol represents an individual mouse (G-I) C57BL/6N mice were treated 
i.v. with 1-1.5mg PyHz followed by i.n. infection with 106 CFU Sp 7 days later. Mice were sacrificed 2 
days after Sp infection and lungs, blood, and spleens were collected for bacterial burden analysis. Data 
(meanS.E.) are pooled results from 3 independent experiments. For all data, each symbol represents an 










Py is a rodent-specific species of Plasmodium, and previous studies exploring 
immune modulatory effects of Hz have typically isolated Hz from P. falciparum infected 
RBC cultures, rather than from organs of infected animal. To address potential 
differences in isolating Hz from organs of previously infected mice, and the ability of 
clinically relevant P. falciparum Hz to suppress innate immunity during bacteremia, Hz 
from P. falciparum infected red blood cell cultures (PfHz) was also tested. Consistent 
with Hz from Py infected mice, PfHz could be detected within some leukocytes in 
peripheral blood following injection, while others remained PfHz-negative (Fig. 23A), 
was quantified in both the spleen and liver (Fig. 23B), and PfHz treated mice had 























Figure 23. Plasmodium falciparum hemozoin (PfHz) is sufficient to impair clearance of ΔactA Lm in 
vivo. C57BL/6N mice treated i.v. with 1mg hemozoin isolated from P. falciparum (Pf) infected red blood 
cell culture (PfHz).  7 days after PfHz treatment mice were infected with 5x106 CFUs ΔactA Lm.  A) 
Giemsa stained peripheral blood smears and cells mounted from spleen and liver single cell suspensions on 
the indicated days post Hz treatment. Arrows indicate the presence of intracellular Hz, visible as brown 
pigment. PfHz-negative leukocytes were present at indicated time points in peripheral blood, spleen or liver 
with no visible intracellular Hz pigment (B) Quantification of Hz in spleens and livers. Data (meanS.D.) 
are from a single experiment representing three independent experiments. Dotted lines represent the limit of 
Hz detection. Bacterial burden in spleens of PfHz (C) or untreated control mice was determined 2 days post 
Lm infection. Data (meanS.E.) are cumulative results from 2-3 independent experiments. Each symbol 




Research concerning the immunomodulatory effects of hemozoin has been 
conducted in a large variety of preparations, relating to drastic differences in molecular 
components associated with the biocrystals, which confer dissimilar results. Thus, we 
performed a series of experiments which aimed to explore how different hemozoin 
preparation procedures, and therefore, surface-associated bioactive molecules impact the 
clearance of Lm.  PfHz was treated with DNase to remove DNA whereas PyHz had not 
been DNase treated. When PyHz was treated with DNase to remove DNA, mice injected 
with DNA free PyHz still exhibited elevated bacterial burden (Fig. 24A-C). In contrast to 
these results, mice treated with ‘clean’ PyHz, which was treated with detergents and 
proteinase K, followed by infection with Lm, showed no defect in the control of Lm (Fig. 
24D). Similarly, mice that were treated with pure synthetic Hz followed by Lm infection, 
also showed no defect in control of Lm (Fig. 24E).  These results support the conclusion 
that the bioactive molecules associated with hemozoin (other than DNA) are involved in 





















Figure 24.  Hemozoin preperation differentially impacts anti-bacterial innate immunity. A) Agarose 
gel containing PyHz samples labeled with GelRed Nucleic Acid stain to detect presence of DNA.  Lane 1 – 
1,000-100 base pair ladder, lane 2 – 15μL sample of 2mg/mL PyHz treated with 10 U/mL DNase, lane 3 – 
15μL sample of 2mg/mL PyHz treated with 100 U/mL DNase, lane 4 – 15 μL sample of untreated 0.3 
mg/mL PyHz, lane 5 – 15 μL sample of 0.3 mg/mL PyHz treated with 100U/mL DNase, lane 6 – 15μL of 
100ng/mL untreated DNA, lane 7 – 15μL of 100ng/mL DNA treated with 100U/mL DNase. B) 
Quantification of DNase treated PyHz in spleens and livers. Data (meanS.D.) are representative of three 
independent experiments. Dotted lines represent the limit of Hz detection. C-E) Lm burdens in spleens and 
livers from mice treated with DNase treated Hz (C), ‘clean’ PyHz (D), and synthetic Hz (E) on the 




So far, we have characterized the contribution of Hz to both the delayed clearance 
of Lm in our Py+Lm coinfection model and demonstrated that Hz impairs antibacterial 
functions of splenic phagocytes.  Our use of the model bacterium, Lm, in our coinfection 
model provided critical insight into how Plasmodium infection weakens host immunity to 
invasive bacterial infections, we next sought to test whether hemozoin has a similar 
impact on the more clinically relevant pneumococcal coinfection model.  Similar to 
experiments in figures 18-20, naïve mice were given intravenous injections of PyHz 
followed by intranasal infection with Sp 7 days later.  Unlike what was observed in Lm 
infections, PyHz did not show different bacterial burdens in the lungs, peripheral blood, 
or spleen compared to control mice (Fig. 25A-C). While this in vivo data does not support 
a role for Hz in Plasmodium-induced susceptibility to invasive Sp infection, it does not 
rule out the possibility.  More work is needed to test this hypothesis further. Collectively, 
the results of this chapter identify Hz with bound bioactive molecules, excluding DNA, 
as a parasite-derived factor that is able to impair anti-bacterial innate immunity to some 








Figure 25. P. yoelii hemozoin with bound bioactive molecules does impair immunity to Sp. C57BL/6N 
mice were treated i.v. with 1-1.5mg PyHz followed by i.n. infection with 106 CFU Sp 7 days later. Mice 
were sacrificed 2 days after Sp infection and lungs, blood, and spleens were collected for bacterial burden 
analysis. Data (meanS.E.) are pooled results from 3 independent experiments. For all data, each symbol 






It has been postulated that Plasmodium-induced immune suppression and 
susceptibility to invasive bacterial infections is not attributed to a parasite-specific factor. 
Rather, it is due to Plasmodium-induced hemolysis, and subsequent activation of HO-1 
and IL-10 that inhibit neutrophil functions lead to weakened immune responses to 
invasive bacterial infections [60]. Yet, we demonstrate that Py-induced immune 
suppression lasts up to 2-months post clearance of Py, when the effects of hemolysis are 
likely no longer in play. Additionally, Cunnington and colleagues demonstrated that 
neutrophils collected from patients previously infected with P. falciparum had defective 
ROS burst following PMA stimulation that lasted up to 8 weeks-post treatment [61]. Of 
note, Hz from P. berghei infection remains deposited in liver, bone marrow, and spleen 
tissues as well as within isolated CD11b+ cells isolated from those tissues and peripheral 
blood of mice for at least 196 days post infection [110]. Collectively, these data provide 
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evidence that a parasite factor, Hz, may contribute to this impaired innate immunity to 
bacterial coinfections and leads to the hypothesis that this factor contributes to clinical 
observations of reduced immunity to invasive bacterial infections in patients with history 
of malaria. 
Using a murine infection model of malaria and ex vivo intracellular bacterial 
survival assays we have determined that Hz is able to impair innate immunity to bacterial 
infections independent of the parasite infection. Of note, we made this observation using 
two different preparations of Hz. First, Hz was prepared via a novel method by extracting 
Hz from organs of mice previously infected with Py. Importantly, DNase treated PyHz, to 
eliminate parasite and mouse DNA, was still capable of suppressing innate immunity to 
Lm in vivo (Fig. 24 A-C). Second, we demonstrated natural PfHz prepared from infected 
red blood cell cultures [84] was able to suppress innate immunity in vivo. These data 
demonstrate that the immune modulatory effect of PyHz is unlikely due to parasite or 
mouse DNA. Whereas parasite or mouse DNA were not implicated in the immune 
suppressive nature of PyHz, PyHz prepared in the presence of detergents and proteases 
(Fig. 24 D), as well as synthetic Hz (Fig. 24 E) did not impair in vivo innate immune 
responses. This supports the idea demonstrated by Carney et al. that the immune 
modulatory effect of Hz is perhaps not due to Hz itself or adherent DNA, but attributed to 
interactions with RBC membrane lipids and other debris that subsequently generate 
highly reactive secondary metabolic products capable of disrupting cell functions (e.g. 
NADPH oxidase and iNOS) upon uptake [185]. Furthermore, lipids within parasitized 
RBCs and hemozoin, such as the hydroxy fatty acids, hydroxy-arachidonic acid (HETE) 
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and hydroxy-linoleic acid (HODE), have been shown to inhibit PMA-stimulated reactive 
oxygen burst in human peripheral blood monocytes [186]. 
Our results suggest the possibility that parasite-derived Hz and bound molecules 
are contributing to the impaired innate immune response to Lm, potentially through 
inhibition of ROS production. While our data indicate that Hz impairs immunity to Lm, 
our ‘native’ preparations of PyHz did not impair immunity to Sp in our model system. 
There are two potential explanations for this observation. First, intravenous injection of 
PyHz may not have resulted in sufficient levels of Hz to suppress innate immunity to Sp. 
This possibility is supported by the observation that Py infection impairs innate immunity 
to Sp long after the clearance of Py (Fig. 9D-F), suggesting a bona fide role for Hz in this 
immune suppression. Second, differences in Hz-driven impaired innate immunity 
between Lm and Sp may be explained by the intracellular and extracellular nature of 
theses pathogens, respectively. Lm is considered an “intracellular pathogen” since it 
grows within cells, whereas Sp is generally thought of as extracellular. Although this is 
not exclusive as Sp can grow in CD169+ splenic macrophages [187].  
 A previous study found that digestive vacuoles isolated from P. falciparum-
infected human red blood cell culture are rapidly phagocytosed by neutrophils in a  
complement-mediated manner [161].  This same group also showed that uptake of Hz 
loaded digestive vacuoles induced a ROS burst when opsonized with active serum, but 
both uptake and ROS burst did not occur if digestive vacuole membrane was disrupted by 
either ultrasonication or detergent treatment [162].  Another interesting finding was that 
internalizing digestive vacuoles by PMNs reduced ROS production in response to 
infection with Staphylococcus aureus and also diminished bacterial killing.  In agreement 
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with the work of Dasari et. al, our purified PyHz and PfHz, which is freed from digestive 
vacuoles, did not impair ROS production of either splenic neutrophils in whole spleen 
single cell suspension or purified bone marrow neutrophils in response to PMA, Lm, or 
Sp (Figure 18 and 19).  Contrary to these studies, however, we were able to visualize 
uptake of PyHz by sort-purified splenic CD11b+/CD11c- phagocytes (Figure 21A) and 
found that PyHz-treatment reduced the ability of these cells to control intracellular 
growth of Lm (Figure 21B and C).   
 When conducting our in vitro analysis of ROS production of PyHz treated whole 
spleen single cell suspensions and purified bone marrow neutrophils, we observed 
massive quantities of intracellular ROS being produced in cells infected with live 
opsonized Sp, nearly 100-fold higher than uninfected cells and close to 10-fold higher 
than heat-killed opsonized Sp or Lm infected cells (Figures 18 and 19).  Furthermore, 
PyHz treated splenic PMNs and cells infected with live opsonized-Sp had significantly 
higher levels of intracellular ROS than cells with no Hz treatment.  As mentioned in 
Chapter III, Sp is resistant to ROS produced by PMNs and produce H2O2 itself [170]. 
This result could be interpreted as an indirect detection of metabolically active 
intracellular Sp, through the production of ROS, and indicate that there is a greater 
amount of unkilled Sp in cells that were treated with PyHz.  Further experiments are 
needed to determine if there is a Hz-dependent defect in the ability of PMNs to kill both 
extracellular and intracellular Sp.  Since it has been discovered that Sp is able to grow 
intracellularly within some subsets of splenic macrophages [187], it would also be 
interesting to explore the possibility that following Hz phagocytosis, Sp is able to grow 
within some leukocytes. 
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Despite the results in experiments with P. berghei mutants that did not support the 
hypothesis that Hz contributes to delayed clearance of Lm in vivo (Figure 20), 
modifications to the coinfection model could be made to improve the system in order to 
better assess this question.  One possible reason for the lack of a Hz-dependent phenotype 
in this model is the relatively low parasitemia and the kinetics of Pb NK65 infection in 
mice.  In Py infection, parasites begin to replicate at detectable levels in the blood around 
5 days post infection and by day 9 parasitemia reaches 10 to 15%.  Mice go on to develop 
acute hyperparasitemia that plateaus between 15- and 20-days post infection around 60% 
(Fig. 4A).  The progression of Pb NK65 is quite different, with parasitemia increasing 
from approximately 1% on day 5 to ~8% on day 9 followed by a continued increase 
[188].  During the early acute Pb NK65 parasitemia, lung weights begin increasing due to 
hemozoin-induced acute lung injury and mice eventually succumb to malaria-associated 
acute respiratory distress syndrome (MA-ARDS) around day 12 post infection without 
complications from cerebral malaria [81, 177].  These differences may contribute to the 
lack of impaired antibacterial immunity observed in the Pb+Lm coinfections.  Another 
complication preventing a definitive conclusion that Hz does not impair clearance of Lm 
is that there was not a significant difference between Hz quantities of liver and spleens of 
Pb Δpm4 (Hz-deficient) infected mice and Pb Δdpap infected mice which serve as a 
control for the attenuated parasitemia of Pb Δpm4 (Figure 20B and C).  To improve this 
model it will be necessary to compare levels of Hz in spleens from Py-infected mice to 
the three Pb strains used here at day 7 and 9 post infection to determine if Pb infected 
mice had lower levels of Hz that may have impacted Lm clearance.   
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Our in vitro data demonstrates the impaired anti-bacterial ability of splenic 
phagocytes either isolated from Py-infected mice or treated with PyHz. Interestingly, the 
analysis of intracellular cfu burdens in our in vitro assay found that splenic phagocytes 
from Py-infected mice, or phagocytes treated with PyHz, contained significantly less Lm 
at 2 hours post infection (with 1 hour in gentamicin) compared to cells from naïve mice 
or untreated cells (Fig. 16C and F). There are several explanations for this result, 
including a defect in Lm uptake, differences in Lm adherence, and altered killing of 
intracellular or extracellular Lm during the time prior to the 2-hour time point.  
Additional work will be needed to further understand the impact of Py-infection and 
hemozoin in these interactions.  Furthermore, cfu counts at 5 hours post infection suggest 
that PyHz treated or Py-infected mouse phagocytes exhibit a profound inability to restrict 
intracellular bacterial growth.  In contrast, there may be a different mechanism 
responsible for Plasmodium-dependent susceptibility to extracellular bacteria. For 
example, serum-dependent effects as we observed (Fig. 15C).  Further studies are 
required to elucidate the mechanisms underlying susceptibility to Sp and other 
extracellular bacterial pathogens during coinfection with Plasmodium. Methods that can 
recognize the presence or absence of internalized Hz at the single cell level would 
substantially enhance our understanding of this interaction. Additional work is also 
needed to uncover the immune cell types affected as well as the antimicrobial functions 
that are impaired by Plasmodium in the context of Sp and other clinically important 
coinfections during malaria. 
Hz may directly impair antibacterial effector mechanisms of innate immune cells 
via uptake or interaction with Hz.  Alternatively, the uptake and recognition of Hz by 
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phagocytic cells could have an indirect effect through altering the host microenvironment 
via the induction of pathways that influence the production of cytokines and chemokines 
in a manner that creates a more favorable environment for invasive/pathogenic bacteria. 
Additionally, Hz has been shown to induce trained immunity [112], suggesting the 
possibility that long-term suppression of innate immunity to systemic bacterial infections 
may in part be attributed Hz-induced epigenetic modifications.   
Clinical reports of invasive bacterial disease coinciding with malaria often report 
both NTS and Sp as the two organisms most commonly isolated from blood. 
Experimental studies to date have focused almost exclusively on NTS and it is unknown 
whether the mechanisms of Plasmodium-induced immune suppression to NTS will be 
important for Sp or other bacterial pathogens found in coinfections with malaria (e.g., 
Haemophilus influenzae, Mycobacterium tuberculosis, Staphylococcus aureus, 
Streptococcus pyogenes, etc. [42-49, 54]). We report for the first time, to our knowledge, 
a murine Plasmodium and pneumococcal coinfection. Mice were infected with P. yoelii 
17XNL followed by a S. pneumoniae ATCC #6303, a type 3 capsule serotype strain, via 
the natural intranasal route. Consistent with the risk of invasive Sp infections in humans 
with malaria [42], we found decreased survival and increased bacterial burdens in co-
infected mice compared to control Sp only infected mice. Murine models of malaria 
associated-respiratory distress syndrome (MA-ARDS) using P. berghei NK65 strain have 
found an association between pulmonary pathology and the levels of Hz deposition [81]. 
Pulmonary pathology matching MA-ARDS has been reported in Py 17X but not Py 
17XNL infection [189]; however, the parasitemia obtained in mice infected with Py 
17XNL in that study were much lower than what was observed in this report where Py 
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17XNL parasitemia reached 40-60%. Consequently, Hz deposition in the lung, and 
potentially in spleen and other organs, may contribute to differential invasiveness of Sp 
during Plasmodium infection. Further studies are necessary to determine to what degree 
Plasmodium, via Hz or other mechanisms, induces lung pathology and to what degree 














FINAL DISCUSSION AND FUTURE DIRECTIONS 
 
 
In this work, we have characterized the impact of Plasmodium infection on 
immunity to 3 different bacterial pathogens using three murine models of malaria bacteria 
coinfections, and a series of in vitro assays.  Our use of Listeria monocytogenes as a 
model bacterium to probe antimicrobial immune responses led us to the findings that P. 
yoelii infection delays clearance of bacteria from the spleen in a model of non-lethal 
systemic infection using and attenuated strain of Lm.  Further investigations led us to 
discover that the impaired innate immune response associated with Py infection lasts long 
after clearance of patent (i.e. detectable), Py infection, and this Py-driven 
immunosuppression occurs independent of IFNγ or the hemolysis-dependent mechanisms 
that have been attributed to the well-characterized increased susceptibility to invasive 
Salmonella disease (HO-1, and IL-10).  Perhaps most importantly, this work 
demonstrates for the first time, that hemozoin, a parasite factor, contributes to impaired 
immunity to secondary bacterial infection.  These findings are summarized in Figure 28. 
Hemozoin had previously been shown to have many effects on in vitro cultured 
cells, yet, inconsistency in source, purification, and preparation techniques have resulted 
in different camps regarding whether hemozoin is immunomodulatory at all or which of 
the surface-bound biomolecules are relevant.  This work has contributed to the 
conversation by showing that Hz alone (“clean” preparation with detergents and protease 
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treatment) did not impair immunity to Lm, whereas Hz containing bound-bioactive 
molecules is sufficient to impair clearance of bacteria from spleens of Lm infected mice.  
We also show in vitro that treating splenic phagocytes with Hz containing bioactive 
molecules decreased their ability to limit the intracellular growth of Lm.   
While we did not provide direct evidence of an Hz-dependent defect in ROS 
production in vitro or enhanced susceptibility to invasive Pneumococcal disease, we have 
two pieces of data that support a role for Hz in the impaired immunity to Sp.  First, our 
observation that Py infected mice are more susceptible to invasive Sp infection not only 
during acute parasitemia, but months after clearance of detectable parasites from the 
blood stream, suggests that Hz is likely involved due to its long-term deposition in tissues 
with known importance in immune responses and active clearance of invasive Sp 
infection [81].  Second, we found an influx of intracellular ROS in PMNs from whole 
spleen single cell suspensions or BMNs isolated from naïve mice when they were treated 
with PyHz and subsequently infected with live opsonized-Sp compared to controls with 
no Hz treatment.  We interpreted this result as potential indirect evidence of greater 
amounts of live, metabolically active Sp in Hz-treated cells.  In fact, Sp can produce large 
quantities of H2O2, and several studies have provided evidence that Sp is not susceptible 
to killing via NADPH oxidase-dependent mechanisms, such as experiments using 
NADPH oxidase inhibitors, and the fact that PMNs isolated from patients with chronic 
granulomatous disease are not defective in killing Sp [190, 191]. Thus, high levels of 
ROS in Hz-treated PMNs infected with live-opsonized Sp compared to cells with no Hz 
treatment could be indirect evidence supporting the hypothesis that Hz treatment impairs 
the ability to kill Sp intracellularly.  It is known that Sp is resistant to oxidative stress, 
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such as ROS produced by PMNs, and is killed by PMN serine proteases.  Both cathepsin 
G and elastase are capable of killing Sp, since the individual inhibition of either did not 
decrease Sp killing in an opsonophagocytic assay, yet treatment with a protease inhibitor 
eliminated killing [172].  Thus, there is apparent redundancy in the capacity of neutrophil 
proteases to sufficiently kill Sp in the context of complement-dependent 
opsonophagocytosis and serine proteases appear to be the main factors in Sp killing.  
More work is required to investigate the hypotheses that the ROS we observed in Hz 
treated PMNs was produced by viable, metabolically active Sp rather than from the 
PMNs intracellular NADPH oxidase-dependent ROS production and that there is indeed 
an Hz-dependent defect in killing of Sp.  The experiments that aim to explore the role of 
Hz in enhanced susceptibility to Sp are highlighted in the future directions section in this 
chapter.  
Considering whether neutrophils acquire their defective antibacterial functions in 
the bone marrow or after entering a tissue will be important in pursuing the mechanisms 
that lead to neutrophil disfunction in Plasmodium infections.  By isolating neutrophils 
from bone marrow of Py-infected and naïve mice and performing experiments testing 
their antibacterial functions in vitro, it would be possible to compare with peripheral 
blood and tissue-isolated neutrophils to determine the origin of the defect. While data 
from Hz-treated PMNs isolated from bone marrow of naïve mice did not demonstrate a 
role for Hz in Plasmodium-induced impaired ROS, other antibacterial functions could be 
tested in this setting.   
A key component of neutrophils arsenal against invading microbes is their ability 
to exocytose granules that contain toxic products.  Of the four granules, gelatinase, 
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specific, and azurophilic types are antibacterial, while secretory vesicles are not [192].  
Release of azurophilic, specific and gelatinase granules by naïve versus Py-infected 
mouse BMNs can be tested in response stimuli by quantifying the surface markers 
associated with each granule type using flow cytometry [193].  In these experiments, 
granule exocytosis can be tested in response to fMLF, TNFα, or Sp with or without 
opsonization from Py and naïve mouse serum.  Given that serum opsonization of 
bacterial pathogens can influence granule exocytosis [194], including different 
preparations of serum in these experiments could help determine the contribution of a 
defective serum component in Py-infected mice.  Other neutrophil functions that would 
be interesting to test, comparing BMNs from Py-infected and naïve mice to tissue-
derived or peripheral blood-isolated PMNs from Py-infected and naïve mice, include 
phagocytic capacity, phagosome maturation and bacterial killing efficiency.  Due to the 
relatively low number of PMNs that can be isolated from peripheral blood of mice, 
samples from several mice can be pooled together in obtain enough cells for the 
conditions needed in the assays, as done in Schneider et al. [195].  
In addition to antimicrobial functions, the ability of neutrophils to migrate to 
infected tissues via chemotaxis could also be examined.  Although greater numbers of 
neutrophils were seen in spleens of Py-infected mice, compared with naïve mice at each 
time point post Py that was examined (Figure 12C), the ability of neutrophils to migrate 
to the spleen in response to an invasive bacterial infection following Py-infection is 
unknown.  A kinetic study of splenic myeloid cells similar to what was conducted in 
Chapter III figures 11-13 could be performed to investigate this, where both naïve and 
Py-infected mice would be infected with Lm or Sp and the quantities of neutrophils in 
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spleens can be determined with the same method.  An in vitro system could also 
investigate the chemotactic ability of neutrophils following Py infection by placing Py-
infected and naïve mouse BMNs, peripheral blood neutrophils, or splenic neutrophils in a 
transwell system and examine their movement across the membrane in response to fMLF, 
IL-8, or IL-12, which is known to be protective in Sp infections by promoting recruitment 
of neutrophils to lungs [196]. 
Since Hz is known to be deposited in bone marrow for up to 140 days post P. 
chabaudi infection and is found in CD11b+ bone marrow cells over 280 days post P. 
berghei [67], any Hz-dependent mechanism influencing the antibacterial functions of 
neutrophils would detectable in an experiment with cells isolated from bone marrow of 
Py-infected mice long after parasite clearance.  Thus, the same neutrophil functional 
responses mentioned above could be examined at timepoints during acute parasitemia at 
15 days post-Py, after clearance of Py infection at day 30 post-Py, two months after Py 
clearance on day 100 post-Py, and even longer to determine the full kinetics and 
longevity of impaired neutrophil functions following Plasmodium infection. 
Another important contribution this work adds to the study of bacterial 
coinfections in malaria is the first murine model of malaria and Pneumococcus 
coinfection.  This model provides an essential tool to study the mechanisms contributing 
to the enhanced susceptibility to invasive Pneumococcal disease that has been described 
in patients with malaria in several clinical reports [42, 45, 47, 49, 52-54, 75, 76, 87].  In 
characterizing this model, we found that Py infected mice had decreased survival and 
higher bacterial burdens in peripheral blood and spleens compared to mice infected with 
Sp alone 3 days after Sp infection.  This impaired immunity to Sp in coinfected mice was 
117 
 
apparent during acute malaria and 2 months after clearance of detectable parasites in the 
bloodstream.  Finally, our results indicated that the activity of Py-induced IL-10 
contributes to the increased susceptibility to Sp in coinfected mice, similar to what has 
been shown in NTS coinfections [59]. 
 Together, our work reveals that Plasmodium infection induces long-term 
immunosuppression that renders the host susceptible to invasive bacterial coinfections 
that lasts beyond resolution of the parasite infection.  Moreover, the data presented here, 
in agreement with clinical observations connecting malaria with increased severity of 
invasive bacterial disease, indicate the importance of obtaining information beyond a 
blood smear in order to account for not only active cases of malaria, but any recent 
history of Plasmodium infection. With the murine coinfection models, and in vitro assays  
described here to test Plasmodium-induced immunosuppression, more discoveries can be 
made to direct efforts to develop treatments and provide further evidence to argue for the 
need of heightened clinical surveillance and perhaps intervention in patients with 
invasive bacterial disease.  
 
Additional directions for investigating Plasmodium-Pneumococcal coinfections 
 
The Py-driven susceptibility/impaired innate immunity to Sp uncovered within 
this work may be occurring by several potential mechanisms that were not examined 
experimentally and there is rationale to further pursue these possibilities.  Although Sp is 
resistant to intra-phagolysosomal ROS [172, 197], the dramatic decrease in Sp-induced 
intracellular ROS response in splenic PMNs from Py-infected mice (Figure 15) suggests 
118 
 
other PMN antimicrobial responses may also be impaired in Py-infected mice.  
Experimental tools are available to investigate PMN antimicrobial responses, including 
inhibitors of specific PMN granules inhibitors of cell signaling pathways.  These 
experiments combined with an assay that tests intracellular and extracellular survival of 
Sp in culture with splenic phagocytes from naïve and Py-infected mice, similar to the 
gentamicin protection assay, would help elucidate specific mechanisms underlying 
impaired immunity to Sp. 
 Previous work has found that inhibition of NADPH oxidase does not affect killing 
of Sp by human PMNs in vitro, suggesting that Sp is not directly killed by PMN ROS 
production [172].  This does not necessarily mean that this defective function does not 
impair PMN antibacterial functions that contribute to Sp killing.  The lack of PMN 
production of ROS seen in cells from Py-infected mice could affect other antimicrobial 
processes that are known to kill Sp, such as the activation of pre-formed neutrophil 
proteases and myeloperoxidase catalysis, which require NADPH oxidase-dependent ROS  
[172, 198, 199].  ROS production is also needed to acidify the phagolysosome to assist 
this bactericidal process [152]. 
 One serine protease produced in high amounts during release of azurophilic 
granules by PMNs, elastase, is known to cleave TLR2, TLR4, and other important 
surface proteins known to recognize Sp [166].  Additionally, the same study found that 
this PMN elastase-dependent activity reduced cellular immune responses following heat-
treated Sp stimulation and reduced survival in an intratracheal model of murine Sp 
infection [166].  Plasmodium infection elicits a release of extracellular serine proteases 
that have been attributed to collateral inflammatory damage during malaria disease [200].  
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Therefore, the serine proteases induced by Plasmodium infection may cleave important 
receptors from innate immune cells, rendering them unable to perform their antibacterial 
effector functions against a secondary Pneumococcal infection.  This hypothesis could be 
tested in our murine model of Py+Sp coinfection with either use of protease inhibitor 
treatment, or conditional knockout mice that lack the ability to produce these enzymes.  
Quantification of surface receptors impacted by protease cleavage could be performed 
with flow cytometry to verify the extent of the Plasmodium-elicited damage, and then 
correlate with a careful characterization of Sp burdens.  
 
Further experiments to explore whether differences in splenocyte populations between 
Py-infected and naïve mice impacts antibacterial immunity 
 
 To follow up the extensive characterization of splenic myeloid cells over the 
course of Py infection (Figure 12),  a similar approach can be used to identify differences 
in cells that infiltrate infected tissues, such as the spleen and lungs, following secondary 
bacterial infection.  By using similar methods (same cell isolation method, antibody 
staining and gating strategy), an experiment could determine whether or not there are 
differences in myeloid cells that enter the spleen (for Lm, Sp, even NTS) or lung (Sp 
only) at 3, 6, 12, 24 and 48 hours after the bacterial challenge between naïve and Py-
infected mice.  A reduction in neutrophil migration to the liver 4 days after NTS infection 
has already been described in  Py-infected mice compared to mice challenges with NTS 
alone [59].  Expanding on the characterization of cell types that have impaired or 
differential mobilization to sites of infection at various times after bacterial challenge 
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would give additional insight into how changes in myeloid cell functions during malaria 
can impact innate immunity to bacterial coinfections.  Since the spleen is impacted 
heavily during Plasmodium infection, and is vital to controlling bacterial infections 
during sepsis, a characterization of myeloid cells mobilization to the spleen following 
bacterial challenge would improve our understanding of exactly which cells are 
interacting with an invasive bacterial pathogen [47].  Dynamics of myeloid cell 
infiltration into lung tissue would also be of interest, given the potential for Plasmodium 
infections to induce lung pathology and the importance of neutrophils and monocytes 
during upper respiratory Pneumococcal infection [81, 172, 200].  Additional experiments 
using a fluorescent bacteria could determine which myeloid cell subsets are able to 
uptake bacteria and a time-course study, where investigators could look at the presence 
and abundance of bacteria within a variation cell types over the course of the bacterial 
infection in naïve and Py-infected mice to understand which cell types are involved with 
the uptake of bacteria, as well as the ability of those cells to control the infection.  Further 
in vitro and ex vivo functional experiments can then be performed on the cells to explore 
potential Plasmodium-driven mechanisms of impaired anti-bacterial functions. 
 A different approach that would enhance the sensitivity, increase number of 
surface proteins that can be analyzed, and eliminate the complications of 
autofluorescence is with the cytometry by time-of-flight or CyTOF method [201, 202].  
By utilizing this more advanced method, splenic myeloid cell populations could be 
identified with higher clarity and it would be possible to identify more distinct trends than 




Identifying and characterizing the contribution of a defective serum component in 
elevated susceptibility to bacterial coinfections in malaria 
 
 A serum factor that was identified in Figure 15, where we saw decreased ROS 
production from PMNs infected with heat-treated Sp that had been opsonized with serum 
collected from Py-infected mice (Py-ops Ht Sp).  This effect occurred in PMNs from 
spleens of both naïve and Py-infected 
mice, but Py-ops Ht Sp exacerbated 
the already  
significant ROS production defect 
compared to cells from naïve mice.  
Interestingly, cells from Py-infected 
mice infected with naïve serum-
opsonized Sp and naïve mouse cells 
infected with Py-ops Ht Sp produced 
comparable levels of ROS.  These data 
suggest that, in addition to an 
underlying defect in ROS production, 
a defective serum component in Py-
infected mice contributes to the Py-
Figure 26. Complement depletion during malaria. Adapted from Mooney et al. 2018 Journal of 
Leukocyte Biology. “Malaria, anemia, and bacterial disease: A neutrophil problem?” Malaria is 
accompanied by systemic complement activation and deposition on infected and uninfected RBCs. 
This decreases concentrations of circulating C3 and C5, and generates anaphylatoxins (C3a and 
C5a), potentially impacting important antibacterial PMN functions and contributing to increased 




dependent impaired ROS response.  There is strong rationale to conduct further research 
on the role of serum-opsonizing factors, namely complement factors, given that it is well 
established that Plasmodium infection activates and eventually functionally depletes 
complement components [120, 203, 204].  The connection between complement 
deficiency was discussed recently[60], where the authors postulate that Plasmodium-
driven complement depletion relates to decreased opsonization of NTS, lower neutrophil 
migration, ROS and TNFα production, and  contribute to impairments in other PMN 
antimicrobial functions in response to NTS (Figure 26).  The first steps needed to 
continue investigating the role of complement in Plasmodium-driven susceptibility would 
to verify that the serum factor involved in the decreased ROS production (Fig. 15) is in 
fact a complement component.  A simple way to test this would be to heat-inactivate 
serum from both naïve and Py-infected mice and repeat the DCF ROS experiments with 
heat-treated Sp.  If a decrease in ROS is found in cells infected with heat-inactivated 
naïve mouse serum opsonized Ht-Sp, the contribution of opsonizing antibodies can be 
ruled out, indicating the defective serum factor in Py-infected mice is a heat-labile 
complement factor. Conversely, experiments could be performed where individual 
complement components could be added to serum from Py-infected mice and incubated 
with Sp preparations prior to infection in order to identify precisely which complement 
protein is responsible for the Py-induced serum defect observed in this work.  After a 
complement factor is identified in vitro, it can be verified in an in vivo  co-infection 




 Quantitative analysis of the complement components in serum of naïve vs. Py-
infected mice would serve as a preliminary screen in an effort to identify a specific 
protein that could be responsible for the defective ROS production function.  This could 
be done either with comparing protein quantities in serum between naïve and Py-infected 
mouse serum via Western Blot, or via detection with a multiplex ELISA kit for 
complement factors or a flow cytometric analysis.  Another approach could be performed 
in vivo with Py+Sp or Py+Lm coinfected mice compared with mice given bacteria alone 
with broad depletion of complement factors via treatment with Cobra Venom Factor 
(CVF) or depletion of specific complement components with some other method [127, 
205].  An important interaction to consider in investigating interactions between 
Pneumococcus and complement is the Sp capsule, which in some cases binds directly to 
complement receptors or complement factors, and Sp capsule-mediated inhibition of 
complement activity [126, 127, 206].  For these reasons, it would be diligent to include 
capsulated, uncapsulated, and potentially a variety of capsular serotypes in any 
experiments involving Sp-complement interactions.  Finally, it would also be interesting 
to investigate the contribution of the defective serum factor we found with defective 
PMN ROS production during Ht-ops Sp infection in an assay where Sp intracellular and 
extracellular viability is determined in coculture with PMNs isolated from naïve or Py-
infected mice, with the different manipulations of serum opsonins described above.  
These experiments would provide mechanistic insight into the Plasmodium-dependent 
susceptibility to invasive Pneumococcal disease that is currently lacking from the field 




Next steps in examining role of hemozoin 
 
 The next steps in characterizing the role of hemozoin in suppression to bacterial 
coinfections will involve determining what specific innate immune cell populations have 
impaired antimicrobial functions and which important mechanism are impacted.  This 
will require either visualization of hemozoin pigment within cells or an analysis method 
similar to what has been described with flow cytometry, taking advantage of the 
birefringent or ultraparamagnetic properties, as done in Frita et. al [207]. This will allow 
analysis of the percentage of cells with intracellular Hz, and with the inclusion of 
antibodies specific to certain innate immune cell subsets, information about the identities 
of the cells and to some degree, the amount of Hz they uptake.  In future experiments 
seeking to identify mechanisms of Hz-dependent impaired antimicrobial function, 
determining cell types with particular defects will be very helpful and obtaining this 
information from in vitro assays will pave the way for experiments with in vivo models 
where susceptibility to bacterial infection is analyzed in Hz treated mice and compared to 
untreated controls. Imagestream® equipment made by Amnis® (Seattle, WA), for 
example, would allow for analysis of fluorescence marker quantification that is paired to 
bright field images at the single cell level and analysis of intracellular Hz has been done 
with this equipment [184].  ROS detection and bacterial uptake, survival, and growth 
would also be detectible with use of DCF, as done in this dissertation, and a fluorescence 
expressing bacteria.  Also, a fluorescent strain of Sp could be used in a DCF assay to 
potentially determine whether Sp is the source of the large amount ROS we observed in 
Figures 18 and 19. 
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In addition to these experiments, more work is also needed to identify precisely 
which Hz-bound bioactive molecules are responsible for the immunomodulatory activity 
of Hz that we have observed.  This can be achieved via careful molecular characterization 
of the different preparations of hemozoin described here. There is reason to suspect that 
the immunomodulatory effects we have observed in both the delayed clearance of Lm 
from spleens of PyHz-treated mice and the inability of PyHz-treated splenic phagocytes 
to control intracellular growth of Lm in vitro (Figures 22 and 21, respectively), is due to 
hydroxy fatty acids described by Schwarzer et al. [186].  Performing the experiments 
described in this work which involve Hz, as well as those mentioned in future directions, 
with de-lipidation treatment used by Schwarzer and colleagues [186]on Hz will provide 
meaningful insight to move the project forward into high-impact mechanistic studies.  
 
RNA-seq analysis to characterize overall effect of hemozoin uptake on myeloid 
cell with systematic function analysis 
Currently, very little is known about how phagocyte antimicrobial functions 
change following the uptake of Hz.  One study has investigated changes in gene 
expression in human peripheral blood monocytes treated with Hz or iRBCs and found 
that Hz and iRBC-treated cells were hyperresponsive in response to a second stimulus 3 
days after Hz or iRBC exposure [112]. A similar RNA-seq approach could be used to 
examine gene expression of ultra-purified Hz-treated and untreated PMNs and 
macrophage cultures with multiple stimuli to determine specific mechanisms by which 
their effector functions are impaired.  Such an analysis would compare mRNA levels of 
these cells with or without Hz treatment followed by stimulation with chemicals known 
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to induce antimicrobial responses, including PMA, LPS, heat-treated Sp or 
Staphylococcus aureus.  Assessing gene expression in cells with or without Hz treatment 
following stimulation could uncover a pathway that is made defective by internalization 
or interaction with Hz in vitro and subsequent testing with gene silencing, knowckout 
mice, or inhibitory molecules specific to pathways of interest can be used to validate 
findings from RNA-seq analysis.  The same method could also be used in comparing 
cells from Py-infected and naïve mice or P. falciparum infected individuals compared to 
healthy controls.  Altogether, the combination of gene expression analysis cells with or 
without Hz treatment and cells from patients with or without malaria would provide 
insight to which defects in phagocyte antimicrobial function are specific to uptake or 
interaction with Hz, and which are independent of Hz and caused by some other factor 
during Plasmodium infection. 
 
Contribution to the Field 
 
Our findings provide evidence that there are multiple factors involved in 
Plasmodium-induced suppression of antibacterial innate immunity. Combinations of 
these factors likely contribute to the enhanced susceptibility to the different bacterial 
pathogens seen in conjunction with malaria in sub-Saharan Africa. Given the increased 
mortality rate associated with malaria and invasive bacterial coinfections, these results 
may provide insight into new approaches to treat those individuals. Finally, this report 
provides the first description, to our knowledge, of a murine model system of 
Plasmodium and S. pneumoniae coinfection. In this model, Plasmodium infections impair 
host immunity to S. pneumoniae, which resulted in increased mortality. As S. 
pneumoniae is one of the most common bacteria identified in individuals with invasive 
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bacterial infections during malaria, this model has the potential to provide further 
knowledge into the dynamics of this coinfection and identify approaches to treat this 
coinfection.  A summary of the mechanisms of Plasmodium-induced immunosuppression 
that have been experimentally explored in models of NTS, Lm, and Sp coinfections can 




Figure 27. Potential mechanisms of Plasmodium-driven immune suppression to bacterial 
coinfections. List of mechanisms of Plasmodium-induced impaired immunity to bacterial co-infections for 
non-Typhoid Salmonella (NTS), Listeria monocytogenes(Lm), and Streptococcus pneumoniae (Sp). Check 
mark = mechanism is known be involved, “X” mark = no experimental evidence that suggests mechanism 
is involved, question mark = mechanism has not been tested for indicated bacterial pathogen. Black marks 
indicate previously known mechanisms while the red marks indicate the results from this dissertation. See 






















Figure 28. Mechanisms of Plasmodium infection-driven suppression of antibacterial innate immunity 
to invasive coinfections.  1) Rupture of parasitized red blood cells during the blood stage of malaria results 
in hemolysis and the activation of HO-1(2) and IL-10 (3), which initiates a positive feedback loop of 
activation. Both HO-1 and IL-10 are known to blunt neutrophil responses such as ROS production and 
impair innate immunity to NTS, while only IL-10 has been found to impair immunity to Sp. Also, via 
mechanisms that are not yet well understood, Plasmodium infection impairs the ability of splenic 
phagocytes to control the intracellular growth of bacteria (4). Activation of the complement system occurs 
during blood stage of Plasmodium infection, leading to their functional depletion. This defect in 
complement or parasite driven changes to opsonizing antibodies are likely responsible for our observations 
that a defective serum factor impairs the ROS response of neutrophils (5).  Hemozoin crystals are 
byproducts of the parasitic digestion of hemoglobin and are released into circulation upon rupture of 
parasitized red blood cells. These crystals are deposited in tissues (6) where they are internalized by 
phagocytes (7) which impairs their ability to control growth of intracellular bacteria (8) and causes 
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Terms, abbreviations, and definitions 
Sp – Streptococcus pneumoniae aka Pneumococcus 
Lm – Listeria monocytogenes  
NTS – Non Typhoid Salmonella 
Py – Plasmodium yoelii – rodent malaria 
Pf – Plasmodium falciparum – causes most cases of human malaria 
Hz – hemozoin – Plasmodium parasite biocrystal byproduct 
Sepsis – bacterial infection in the blood 
Bacteremia – bacterial infection in the blood 
Hemolysis – lysis (bursting open) of red blood cells, like when parasites burst out.  Kills 
the cell 
Parasitemia - % of red blood cells that are infected with the parasite 
hyperparasitemia – high levels of parasitized red blood cells (over 5% in humans, over 
20% in mice) 
Colony forming units (CFU) – the unit that we use to measure amount of bacteria (1 
CFU= ~1 single bacterium)  
Neutrophil/polymorphonuclear cells (PMN) – fast acting innate immune cells. they 
enter an infected tissue and gobble up bacteria and kill them quickly 
Macrophages  - more long term/always ready innate immune cells.  Also gobble up and 
kill bacteria, but not as quickly. 
Flow cytometry – method for counting and characterizing cells.  Uses lasers to detect 
different things and can tell you what type of immune cell are in a sample, or how the 
cells are functioning 
HO-1 – Heme oxygenase-1: an enzyme produced after hemolysis, weakens some 
immune cell functions 
Sn PP – a molecule that inhibits HO-1 activity 
IL-10 – an anti-inflammatory signal made by cells when the immune system is trying to 
regulate or decrease potentially harmful levels of inflammation. 
Anti-IL-10 antibody – an antibody treatment that blocks the activity of IL-10 
Reactive oxygen species (ROS) – chemicals like hydrogen peroxide, free oxygen (O2) 
produced by innate immune cells to kill bacteria 
Opsonization – Molecules within the blood (serum) that can attach to pathogens and 
label them for destruction.  Immune cells can find opsonized bacteria easier and have a 
more robust response against them 
Serum – everything in the blood other than red blood cells(or other cells) and 
coagulation factors. 
PMA – A chemical that induces ROS production from immune cells when put into 
culture  
DCF – A chemical that fluoresces in the presence of ROS inside of cells.  Used to 











LAY AUDIENCE SUMMARY 
 
My project is focused on understanding how malaria weakens immunity to 
bacterial infections.  I identified a parasite by-product that is capable of causing this 
immune suppression.  I also created and characterized the first model system of a 
Plasmodium and Pneumococcus coinfection, a common and clinically important 
coinfection in sub-Saharan Africa, and demonstrated that the Plasmodium infection 
enhances the severity and mortality of pneumococcus.  Finally, I identified immune cell 
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2017-2018  Program Coordinator for Louisville Science Pathways Summer 
research internship program for local high school students  
2015- 2017 Graduate Student Council Representative for the Microbiology and 
Immunology Student Organization, Co-Chair of Health Science 
Campus Group 
TEACHING & MENTORING EXPERIENCE:  
2018 Mentored local high school student recipient of the Microbiology 
& Immunology Summer Translational Experience Award.  
2018 Attended Instructional Strategies in Science Education 
Course 
2017-2018  Presented  lecture titled “Immune Cell Functional Assays” in 
Methods in Microbiology and Immunology 
2016 Completed STEM Graduate Teaching Academy 
SERVICE & VOLUNTEERING:  
2019  Volunteer for “Girls Rule! STEM Education Summit” for University of 
Louisville Science Policy and Outreach Group(SPOG) 
2015-2019  Science Fair Judge for the Louisville Regional Science Fair  
2015-2016  Science Outreach Volunteer for GEAR UP Pre-Professional Academy  
2011  Salmon Steward for Thurston County Parks and Recreation 
2010-2011  Science Fair Judge for Roche Colorado Regional Science Fair  
